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Abstract 
Introduction: Cognitive difficulties are evidenced in opiate-dependent populations, whether 
they are caused by drug use per se, or other associated life-style factors. To date no research 
exists which explores the subjective experience of cognitive impairment in opiate-dependent 
populations attending drug and alcohol services. In comparable fields such as brain injury and 
dementia, the subjective experience of cognitive impairment has been explored with important 
and beneficial results. 
Method: Using a qualitative design, data were collected from in-depth interviews with six 
working-age adults with a diagnosis of opiate-use disorder, attending a service for opiate-
substitution therapy, who self-identified as experiencing memory and thinking difficulties. 
Transcripts were analysed in accordance with Interpretative Phenomenological Analysis. 
Results: Three superordinate themes emerged: “a damaged brain and mind” which included 
the extent of the impairment and how participants made sense of such difficulties; “perceptions 
of the self as spoiled” which explored the perceived changes in independence and dependence 
and resultant negative feelings about the self; and “coping with a lesser self” which included 
acceptance and adaptation, and familiar but maladaptive coping strategies. 
Conclusions: Participants’ understanding and experience of their cognitive difficulties 
contributed to their sense of well-being, and further impacted on chosen coping strategies. 
Consideration of cognitive impairment is important to effectively support individuals attending 
drug and alcohol services.  
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PART 1: RESEARCH – EMPIRICAL PAPER 
 
Exploring the experience and understanding of cognitive impairment in chronic opiate-
users. 
Abstract 
Introduction: Cognitive difficulties are evidenced in opiate-dependent populations, whether 
they are caused by drug use per se, or other associated life-style factors. To date no research 
exists which explores the subjective experience of cognitive impairment in opiate-dependent 
populations attending drug and alcohol services. In comparable fields such as brain injury and 
dementia, the subjective experience of cognitive impairment has been explored with important 
and beneficial results. 
Method: Using a qualitative design, data were collected from in-depth interviews with six 
working-age adults with a diagnosis of opiate-use disorder, attending a service for opiate-
substitution therapy, who self-identified as experiencing memory and thinking difficulties. 
Transcripts were analysed in accordance with Interpretative Phenomenological Analysis. 
Results: Three superordinate themes emerged: “a damaged brain and mind” which included 
the extent of the impairment and how participants made sense of such difficulties; “perceptions 
of the self as spoiled” which explored the perceived changes in independence and dependence 
and resultant negative feelings about the self; and “coping with a lesser self” which included 
acceptance and adaptation, and familiar but maladaptive coping strategies. 
Conclusions: Participants’ understanding and experience of their cognitive difficulties 
contributed to their sense of well-being, and further impacted on chosen coping strategies. 
Consideration of cognitive impairment is important to effectively support individuals attending 
drug and alcohol services.  
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1.1 Introduction 
1.1.1 Opiate-use and cognitive impairment 
The aetiology and nature of cognitive impairment is varied (Lezak et al., 2012). Specialist 
services, e.g. memory clinics and head injury rehabilitation centres, exist to diagnose and offer 
support for cognitively impaired individuals, recognising that an individual with significant 
cognitive impairment requires specialised support tailored to their needs.  
A large body of quantitative research has been dedicated to exploring cognitive impairment in 
long term opiate-users (Baldacchino et al., 2012; Baldacchino et al., 2017; Ersche & Sahakian, 
2007; Ornstein et al., 2000). Research to date suggests that long term opiate-use impacts an 
individual’s cognitive functioning, most likely caused by factors associated with illicit drug 
use rather than opiates per se (Darke, Sims, McDonald, & Wickes, 2000). For example, non-
fatal overdose can cause anoxia and concomitant alcohol abuse can result in alcohol related 
brain injury. Furthermore, traumatic head injury can result from a lifestyle of crime and 
aggression associated with a motivation to commit crime, as a result of opiate-dependence and 
an expensive addiction (Department of Health, 2017). 
Existing meta-analyses focused on establishing the presence and extent of cognitive 
impairment in chronic opiate-users (Baldacchino et al., 2012; 2017). These reviews reported 
significant and reliable cognitive impairment across many domains, including cognitive 
impulsivity and flexibility, attention, short term and long term memory. Despite this evidence, 
specialist services do not exist to support individuals with long-term opiate dependencies and 
cognitive impairment. These meta-analyses focused on establishing the causal role of opiate-
use alone on cognitive functioning, and as a result excluded a number of studies on the basis 
of participant complexity, i.e. past or present drug or alcohol use/dependence. It is important 
to consider the heterogeneity of an opiate-dependent population. Figures from Public Health 
England (PHE) indicate that a significant proportion of opiate-users in treatment also present 
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with other drug dependencies, including 42% with crack cocaine, 20% with alcohol, 18% with 
cannabis, and 11% with benzodiazepines (PHE, 2017a). Cognitive impairment is likely to be 
multi-factorial (Darke et al., 2000) and excluding these individuals from research and reviews 
may result in an underestimation of impairment reported in people with an opiate-use disorder.  
A literature review was carried out to identify and evaluate studies investigating cognitive 
impairment in a more typical and heterogeneous sample of opiate-users in treatment. Of the 19 
studies that were reviewed, 17 reported that people in treatment for opiate-use disorder 
performed significantly worse than healthy controls when tested on certain psychometric tests 
across a broad range of cognitive domains (attention and information processing, short and 
long term memory, cognitive impulsivity, non-planning impulsivity, and cognitive 
impulsivity). Despite the literature reviews aims, there was a paucity of studies which included 
participants reporting commonly occurring co-morbidities in drug-using populations, such as 
other drug and alcohol use, head trauma, and mental health diagnoses. Evidence suggests drug-
users with concurrent mental health diagnoses have poorer psychosocial functioning (Kennedy 
& Paykel, 2004), and experience more relapses (Trivedi et al., 2008). Opiate treatment 
completion rates remain the lowest of all substance groups (26%) and it is important to consider 
factors that may impact this (PHE, 2017b). PHE states “a large proportion of the opiate-users 
in treatment have entrenched long term drug use, are often in ill health and less likely to have 
access to the personal and social resources that can aid recovery, such as employment and 
stable housing. These factors result in opiate-users being less likely to complete treatment 
successfully and/or sustain their recovery when compared to users of other drugs and alcohol 
alone” (PHE, 2017a). 
1.1.2 Consequences of cognitive impairment 
The recent UK Guidelines on Clinical Management of drug misuse and dependence (DoH, 
2017) state that cognitive impairment is associated with poor retention in treatment, reduced 
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likelihood of achieving abstinence, and a greater risk of relapse. Better understanding the nature 
of cognitive impairment in a typical opiate-dependent population in treatment could identify a 
need for such deficits to be considered. Deficits on particular cognitive domains are likely to 
have profound consequences for individuals engaging in drug addiction treatment. Slower 
processing speed results in difficulties performing learnt tasks, which can consequently impact 
everyday routines such as arriving at appointments on time, participating effectively in 
therapeutic activities and completing tasks outlined in treatment. This could feasibly lead to 
frustration and disengagement if services do not take into account these deficits and make 
necessary adaptations. Prospective memory impairment could have real world consequences 
such as forgetting to attend appointments or taking medication (Terrett et al., 2014).  
1.1.3 Qualitative research and cognitive impairment 
So far, research on cognitive functioning in substance-dependent populations is dominated by 
quantitative studies focused on identifying the presence and extent of impairment. Research is 
lacking with regard to how these deficits impact people’s lives, and how they are understood 
and managed. This gap is in contrast with other contexts including cognitive impairment in 
traumatic brain injury (TBI) (Levack et al., 2010) and dementia (Qazi et al., 2010). Qualitative 
research has investigated the impact of memory and thinking difficulties in people with a 
diagnosis of mild cognitive impairment (Lingler et al, 2006; Parikh et al., 2015). Findings 
indicated that mild memory changes had a notable impact on an individual’s feelings and views 
about the self, social relationships, and engagement in work and leisure activities. People varied 
in how they made sense of their diagnosis; positive appraisals were associated with relief and 
satisfaction, and negative appraisals were associated with fear and distress. Factors such as 
shame and embarrassment, burden, frustration with memory problems, and loss of self-
confidence reflect the far-reaching impact of a ‘mild’ cognitive impairments on all aspects of 
life (Joosten-Weyn Banningh et al., 2008). Qualitative research exploring the experience of 
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cognitive impairment in epilepsy also indicated that an individual’s mood, social experiences 
and self-representation can mediate the relationship between TBI and a positive outcome (Di 
Battista et al., 2014). Furthermore a recent study investigated the subjective experience of 
cognitive impairment in psychosis (Wood et al., 2015). Participants identified a number of 
thinking difficulties including blanking and forgetting, concentrating, and thinking ahead. Such 
deficits resulted in a range of management strategies including coping alone and hiding, 
becoming dependent on others, or using expertise. These studies show the value of 
understanding service-user perspectives of living with cognitive difficulties. Understanding 
service-user experiences supports a recovery-focused approach (Gould, 2012), and reflects 
guidelines which emphasises the importance of seeking service-user experiences to guide 
service delivery (DoH, 2011). 
However, in a review of the literature, no qualitative studies were found which focused on 
opiate-user’s subjective experiences of cognitive impairment. Nonetheless, the need for 
qualitative research in the field of addictions has been noted. Larkin and Griffiths (2002) 
emphasised that qualitative research can help develop a more detailed and nuanced 
understanding of addiction, noting that self and identity are integral to the subjective experience 
of addictive behaviours. Exploring individuals’ subjective experiences of phenomenon such as 
cognitive impairment will support this process. 
1.2 Objectives 
This research is an exploratory study which uses Interpretative Phenomenological Analysis 
(IPA) to gain a deeper understanding of the lived experience of opiate-dependent individuals 
who self-identify as living with memory and thinking difficulties. The aim is to explore how 
individuals’ describe their memory and thinking difficulties, and their impact. A qualitative 
method is used to explore how these individuals make sense of and manage their difficulties. 
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2.1 Method 
2.1.1 Sampling Strategy 
Six participants were purposively recruited to take part in an in-depth interview. A small 
sample size was necessary to ensure each interview could be analysed in an idiographic, 
detailed, and iterative manner, all within this project’s timeframe (Smith et al., 2009). The 
sample size was also guided by existing studies which used IPA to explore individuals’ 
experiences of cognitive impairment (Howes et al., 2005; Watson & Parke, 2011; Wood et al., 
2015). 
To be included in the study individuals were aged 18-65 with a primary diagnosis of opiate-
use disorder, and were attending an NHS drug and alcohol service in the South West of London. 
Participants had to identify as experiencing “memory and thinking difficulties”, and be 
prescribed an opiate-substitution drug, such as methadone or buprenorphine. To identify a 
reasonably homogenous participant group in accordance with IPA requirements, individuals 
had to be in treatment for their opiate addiction for over five years, establishing a stable yet 
chronic group.  
Participants could take part if they reported using other drugs and/or alcohol, co-morbid mental 
health diagnoses, and were taking related prescribed medications. This was to ensure the 
sample reflected the complexities of a typical opiate-using population (PHE, 2017a). 
Participants were excluded if they had an intellectual disability defined as IQ<70. Participants 
were required to be sober from alcohol and not intoxicated or withdrawing from drugs at the 
time of the interview, to ensure appropriate risk management and to ensure the individual was 
able to complete the interview. The researcher used their clinical judgment to determine if the 
individual was able to take part at the time of interview and did not complete interviews with 
intoxicated individuals.  
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2.2 Design and Procedure 
 2.2.1 Recruitment 
The researcher attended fortnightly “recovery groups” to recruit from a total of 20 individuals 
attending as part of their treatment program. These groups were mandatory for people who 
were in the service longer than five years and perceived as resistant to recovery, based on their 
difficulties in coming off the prescribed opiate-substitute. A recovery worker introduced the 
study, and handed out posters and information sheets in the group (appendix 2&3). Following 
this, the researcher attended the group and interested individuals could leave the session to take 
part. Recovery workers were also asked to discuss the study with their clients (who were not 
attending the group described above) who struggled with memory and thinking difficulties, and 
posters were handed out. If an individual was interested in taking part in the study the recovery 
worker booked an appointment for the individual to meet the researcher. Posters advertising 
the study were also placed within the service building. Participants were offered a voucher of 
£10 for an agreed outlet store, subject to completing the study. Although it was relatively easy 
to identify potential participants in this service, people showed little interest in taking part, 
therefore an incentive was used to increase motivation.  
The meeting between the researcher and interested individuals took place in a private room at 
the service. After a brief description of the study’s aims, inclusion/exclusion criteria were 
assessed. Individuals were asked to provide examples of memory and thinking difficulties. 
Individuals were informed that the interview would take up to an hour, and could take part 
immediately, or at a suitable time in the future. The researcher read aloud the information sheet 
and gave time for questions throughout. The consent form was then completed (appendix 4). 
The researcher explained the confidentiality agreement; information would only be shared 
outside of the research team if the researcher was concerned about the safety of the participant 
or others. 
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 2.2.2 Interview 
The development of the interview schedule (appendix 5) was guided by the research question, 
guidance on IPA interview development (Smith & Osborn, 2008), supervision, and a 
comparable IPA study (Wood et al., 2013). Furthermore, individual consultations with three 
members of a service user group at a community substance misuse service were completed. 
Questions were piloted on these individuals to ensure acceptability and clarity of questions. 
These processes guided further development of the interview schedule. An empathic and 
questioning approach was used both to understand the experience from the participant’s point 
of view, and to help illuminate and make sense of their experience. The interview schedule was 
used flexibly and the participant played an important role in what was discussed. The interview 
began with specific questions to help contextualise the participant, i.e. employment status, 
relationship status, drug taking histories, and mental health diagnoses. The semi-structured 
interviews lasted between 30-45 minutes. The interviews were audio-recorded and 
subsequently transcribed anonymously. After the interview participants had the opportunity to 
ask questions and learn more about the project. Participants were given a £10 voucher in 
compensation for their time, a copy of the information sheet, their consent form, contact details 
of the researcher, and a hand-out of memory management strategies (appendix 6). 
2.3 Ethics 
Ethical approval was obtained from an NHS Research and Ethics Committee, and the Research 
and Development department from the relevant NHS Trust. The study was sponsored and 
funded by the University (appendix 7-9). 
2.4 Data Analysis 
2.4.1 Interpretative Phenomenological Analysis 
IPA fitted the aims of the project to explore cognitive difficulties from the participants own 
perspective, understanding their individual experiences, and gathering information about their 
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relationship to their cognitive difficulties with regard to their understanding, the emotional 
impact, and their coping (Smith et al., 2009). IPA has been applied successfully in other studies 
seeking to understand the experience of cognitive impairment in different contexts; psychosis 
(Wood et al., 2015), dementia (Qazi et al., 2010), and traumatic brain injury (Levack et al., 
2010).  
IPA techniques were followed according to Smith and colleagues (2009) method (see appendix 
10 for more details). All interviews were transcribed clean verbatim by the researcher and notes 
regarding laughter and long pauses were included. Transcriptions were read and re-read, whilst 
also listening to the audio-recording. Themes were searched for one participant at a time, and 
then collated across participants. The process was iterative at all stages and involved checking 
meaning in the data continually. Differences between participants were not ignored and 
variation between each individual was considered, in light of possible heterogeneities. 
Superordinate and subordinate themes were identified and developed into a conceptual 
framework, with examples provided from the data in the form of quotes  
2.4.2 Quality Assurance 
 
Yardley’s (2000) framework (appendix 11) was used to support the study’s validity and 
reliability at all stages, as recommended for IPA (Smith et al., 2009). A reflexive diary was 
kept by the researcher to develop their awareness and understanding of personal assumptions 
and to identify the potential impact of these biases at all stages of the research project.  Being 
transparent about assumptions and expectations aimed to reduce their potential influence on 
data collection and interpretation, therefore reducing the impact of bias (Fischer, 2009). 
However objectivity is not an aim within IPA, instead the study hopes to offer a plausible 
account of the data using examples in the form of quotes to offer substantive evidence for the 
results (Larkin & Griffiths, 2002). Examples of self-reflexivity and credibility checks can be 
found in the appendix 12-14.  
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3.1 Results1 
To protect participants’ anonymity and confidentiality, age and ethnicity neutral aliases have 
been used (table 1). Table 2 gives an overview of demographic information for the participants. 
Table 1 
Participant Aliases 
Participant Number Participant Alias 
1 Jack 
2 Matt 
3 James 
4 Emily 
5 John 
6 Robert 
 
Table 2 
A summary of demographic information across the sample 
Demographic Information Sample (n=6) 
Age (range) 38-55 years 
Gender 5 Males: 1 Female 
Ethnicity 4 White British: 2 Other 
Length of opiate-use (range) 16-40 years 
Type of opiate-substitution 4 Methadone: 2 Buprenorphine 
Time taking opiate-substitution 
(range) 
5-10 years 
                                                     
1 ‘[]’ indicates missing material 
‘…’ indicates a pause in the participants’ parlance 
‘[word]’ indicates added material to clarify what a participant is referring to 
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Demographic Information Sample (n=6) 
Employment status 6 Unemployed  
School-leaving age (range) 13-17 years 
Partnership status 2 Co-habiting: 4 Single 
Other diagnoses Depression (4); Hepatitis C (2); Chronic pain (1); 
Diabetes (1) 
Other current drug use Cannabis (4); Crack cocaine (2) ; Benzodiazepines (1); 
Alcohol (4) 
Prescribed medication Benzodiazepines (2); Anti-depressants (4) 
3.1.1 Overview of themes 
Interpretative phenomenological analysis of the six semi-structured interviews revealed the 
master themes and sub-themes, outlined in table 3. The themes are then explored and 
interpreted in a narrative account using verbatim quotes from the interviews. Nuances and 
individual differences between participant experiences are highlighted and considered 
throughout. 
Table 3 
Master themes and related sub-themes 
Master themes Sub-themes 
 
A damaged brain and mind 
Memory and thinking difficulties impact 
everyday functioning 
Making sense of what caused the 
impairment 
Perceptions of the self as spoiled 
[by the damaged brain and mind] 
Perceived changes in independence and 
dependence 
Negative feelings towards and about the self 
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Coping with a lesser self Acceptance and adaptation 
Familiar but maladaptive coping strategies 
 
The first theme, ‘a damaged brain and mind’ explores how participants perceived and described 
the difficulties they experienced with memory and thinking, how these impacted their everyday 
functioning, and the process of trying to make sense of why these problems exist. Participants’ 
experiences are considered in relation to contextual factors which could help explain individual 
differences in the experience of impairment, such as the stage in their journey. Data suggest 
that an individual’s perception and understanding of such difficulties influenced their 
perception of themselves as spoiled. This second theme includes evidence of participants’ 
perceptions of changes in their level of independence and dependence, and resultant negative 
feelings about the self. The extent to which a person identified with having a damaged mind, 
and their perceived control over its cause, influenced the extent to which perceptions of their 
self was negatively impacted. Changes to an individual’s independence, which were often 
associated with negative feelings, led to a need to cope and manage, which is explored in the 
third theme ‘coping with a lesser self’. Again, participants’ stage in coming to terms with their 
difficulty impacted their chosen coping strategies. Participants’ varied from processes of 
ambivalence and denial to accepting and adapting to the impairment. Less adaptive coping 
strategies were prevalent across all participants, irrespective of their stage in their journey, and 
drug use appeared as a familiar coping mechanism for difficult feelings and experience. 
3.2 A damaged brain and mind 
3.2.1 Memory and thinking difficulties impact everyday functioning 
Five participants reported difficulties remembering recent experiences and events. Matt said “I 
just don’t remember days or whatever [] I can’t remember what I did bloody last week, I can’t 
remember yesterday”. Matt’s use of the word ‘bloody’ and his exasperated tone suggested 
recalling this information was uncomfortable for him, he later shared he had not realised the 
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extent of the impairment before now, saying “what the f*** (laughs)… that happens a lot 
actually now I think about it”. The long pause suggested Matt was going through a process of 
realisation, and his use of emotive language and laughter suggested this was a poignant moment 
for him. Other participants appeared more familiar with their impairment, as Robert stated in a 
matter-of-fact manner “I just don’t remember”. This suggested Robert was holding a position 
of acceptance of his impairment, contrasting Matt’s experience, who wondered whether 
“everyone has it [memory difficulties]”. Matt struggled to reflect on his experiences often 
saying “I don’t know, I can’t answer that”. The anxiety Matt felt facing up to his impairment, 
evidenced by him saying “I mean it’s memory isn’t it memory loss, and I don’t like saying I 
have memory loss” may have impeded his ability to reflect, as well as the possibility that he 
had not before thought about such issues. Matt’s discomfort in accepting his memory loss was 
further explicated when he shared, “it’ll [memory loss] probably get worse I mean my dad’s 
got it, Alzheimer’s, we’ve only just found out [] I dunno if it runs in the family does it?”. This 
comment suggested Matt was fearful of whether he may develop Alzheimer’s in the future. 
Such fear and uncertainty may have made it more challenging to accept and reflect on his 
memory difficulties.  
Evidence suggested Matt and Robert might have been at different stages in making sense of 
their impairment. Matt’s younger age and shorter length of opiate-use could mean he was 
behind Robert in his journey to realising the extent of the impairment. Furthermore Robert’s 
diabetes meant he had already faced up to his memory difficulties, receiving input from 
services to support his medication adherence which had been poor due to memory problems.  
Robert and Matt may have also varied in the overall severity of their impairment. In contrast 
to Matt, Robert explored how his memory impairment impacted his daily life, “It was only two 
weeks ago I put a pie in the oven, and completely forgot about it”. On further exploration it 
seemed difficulties with attention better explained his experience as Robert clarified that 
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interruptions easily distracted him away from a task, saying “and in that instant because I know 
now I’ve got to be somewhere else [] I’ve forgotten that I’ve put the oven on”. The term ‘and 
in that instant’ suggested a quick and automatic process that Robert felt little control over. John 
further stated “as soon as 3 or 4 different issues that I need to deal with [] there will always be 
1 or 2 that I forget”. The word ‘always’ indicated a sense of inevitability over his difficulties, 
and the impact of this is considered later. 
Four participants talked of difficulties remembering upcoming events. Jack commented “I 
won’t attend my appointments, most the time I forget” and Robert said “If you look at my 
appointment record here it’s been terrible because I just keep forgetting”. John said “I think 
missing appointments here has been a nightmare, an absolute nightmare”. These participants 
outlined how their cognitive impairment directly impacted their ability to engage in treatment 
and work towards recovery, and the impact of this is considered further in the following themes.  
Some participants spoke of difficulties remaining in the present, Jack said “my eyes are there 
but my brain is not”, whilst James shared “It’s coming in but I don’t remember what I’m 
watching”. These comments bear resemblance to the phrase ‘the lights are on but there’s no-
one home’, a statement of loss of self, which is explored in the second theme. 
 3.2.2 Making sense of what caused the impairment 
Participants went on to attribute these impairments to a damaged brain which they considered 
to be caused by factors such as drug use, harm from others, and other organic causes. Matt’s 
sense-making process continued as he considered different causal factors for his difficulties, 
on one occasion saying “cus I’m abusing myself [] it makes me forget stuff”, and on another 
saying “maybe it’s in there anyway, maybe it’s f****** in my head and like years to come I’ll 
end up with f****** Alzheimer’s or something”. These aetiologies differed in where the blame 
is placed, internally (Matt said “it’s self-inflicted”) or externally (Alzheimer’s). Matt was open 
about his continued drug and alcohol use, and his ending comment “if we weren’t abusing 
19 
 
ourselves we probably would remember”, suggested he believed the impairment to be related 
to intoxication of substances, rather than a result of lasting damage. His statement suggested 
he believed his memory would recover if he stopped using drugs and alcohol, suggesting he 
felt in control of his impairment. Matt’s sense of control might help explain his reported lack 
of negative emotions, explored in the second theme. Interestingly, Matt’s use of the term ‘we’, 
could suggest that he experienced his peer group as also having memory difficulties, which 
could have reduced the levels of associated distress as he perceived himself as no different to 
his peers. It might also have suggested that Matt was struggling to accept he was more impaired 
than others. In contrast, Emily said “when I was drinking it was terrible but it has got better 
but I’m not back to normal, I’ve done permanent damage definitely”. Emily, who no longer 
drinks, had personal experience of the impairment persisting outside of substance misuse; a 
situation Matt had not experienced. Feeling little control over the extent of the difficulties were 
consequently associated with a range of negative emotions, explored below. 
Other participants also considered multiple causes for their difficulties, varying with regard to 
locus of control. Jack repeatedly made comments such as “I think if I take this medication my 
brain is blocked [] and it [medication] has blocked my mind”. Jack’s use of the word ‘blocked’ 
suggested the interference of another agent i.e. medication, which was out of his control. Jack’s 
comment about his “mind going a different way” further suggested the lack of control he felt 
over these changes. Jack also linked early experiences of trauma with his memory difficulties 
“and after that [trauma] it was lots of affect my memory, that was the start”. James and John 
shared experiences of trauma which they linked to their cognitive impairment. John said “I got 
hit on the head with a hammer [] once I had the head injury [] my memory then was just 
terrible”. James said that “I got beaten very badly [] it get worse actually [after that], it was 
before too”. These explanations located the control externally and the impact of this is 
considered later. As well as John’s head injury he also said “I think the drugs did have a part 
20 
 
in the memory loss”. These comments reflect the complex nature of cognitive impairment in 
drug-users. The interview reflected a sense-making process for some participants, allowing the 
opportunity for to-ing and fro-ing between possible explanations. This could reflect the 
possibility that participants had not yet made sense of their difficulties.  
3.3 A self that is spoiled (by the damaged brain and mind) 
3.3.1 Perceived changes in independence and dependence 
Participants talked about how their impairment resulted in an inability to depend on themselves 
to manage and cope with everyday life. When talking about treatment engagement, Robert 
explained “I got to remember when it is what time it is and I can’t I know I can’t do it I know 
I can’t do it. I wish I could”. His repetition of ‘I can’t’ served to emphasise and reinforce his 
belief in his inability, reflecting the idea that the more something is said the truer it becomes, 
defending his experience of impairment. Robert went on to say “I feel lucky if I can remember 
your name”. Use of the words ‘luck’ and ‘wish’ indicated his perception that he has no control 
over his memory, it instead being down to chance or good fortune. The uncontrollability and 
inevitability of memory failure was also present in John’s comments, who said “I’ll always 
forget something. Always. Guaranteed”. Using complete statements emphasised his certainty, 
relaying these statements as fact rather than beliefs or perceptions. John emphasised that even 
if he does try to support his memory, he could still fail, saying “but even though sometimes 
when I’ve written stuff down I will still forget them [] unless they’re in front of me”. John 
suggested that the strategy does not manage the memory difficulty effectively, as ultimately 
the usefulness of his memory aids depend on his own abilities, which were perceived as poor. 
For John and Robert there was a sense that even if they wanted to achieve something, they 
could not.  
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These comments related to a low sense of self-efficacy, a concept which reflects how capable 
an individual feels in carrying out a behaviour (Bandura, 1977). The perceived 
uncontrollability of the impairment contributed to feelings of low-self efficacy, and were 
further associated with a range of difficult feelings (discussed below). In contrast, Matt 
portrayed a stronger belief in his abilities to remember, stating “writing shit down so you 
remember, I’m not that bad”. This comment suggested that Matt’s perceived abilities to 
remember without aids was good, with little change to his perceived independence. As 
described above, Matt also felt a sense of control over the impairment, and when compared 
with the other participants, he spoke least about negative feelings about the self.  
A corollary of participants believing they could not depend on themselves, was the need to 
depend on others to manage everyday life. The two participants who were in a relationship 
talked about the importance of their partner. Jack said “most often my wife has to remind me 
to take my medication”, and John said “my partner noticed all the time, you’ve forgotten to do 
this you’ve forgotten to do that”. These comments indicated that without their partners support 
they would likely be functioning less effectively. Their relationships had a new focus as a result 
of the cognitive impairment, as the individual perceived themselves as needing an increased 
level of support. Both reflected on how they felt a burden in the relationship, for example Jack 
said “always we [me and my wife] have a problem [] sometimes even my wife she is crying, 
she says I don’t know what happened to you, you don’t remember even nothing [] and that’s 
everything is make me just feeling so bad”. This highlighted a discrepancy between the person 
Jack used to be, the person he is now, and the person his wife wants him to be, a gap known to 
contribute to negative feelings about the self (Higgins et al.,1985). Furthermore Jack was aware 
that the cognitive impairment not only affected himself, but it also affected others, saying “I 
worry about my kids [] more than everybody it affects my kids”. Jack shared the ‘bad feelings’ 
he experienced as a result of letting others down, and further commented “my son thinks I don’t 
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want to spend time with him or play with me”. This experience may have been more difficult 
to bear than letting himself down. Later Jack reflected on his desire to be alone, reducing 
opportunities for disappointment, saying “I don’t want nobody come to visit me because it make 
you know upsetting people [] I don’t want to feel I’m a rude person”. The impact of this coping 
strategy is explored in the final theme.  
All other participants were single and spoke more about their dependence on professionals. 
James said “if it wasn’t for [name of recovery worker], I would lose all appointments”, and 
Robert said “and now they [professionals] put it [medication] all in dosette boxes [] they sort 
it out for me”. These comments highlighted the reliance on other people to manage and cope, 
and further reflected the severity of the consequences if this support were not available; for 
example Robert said “very easily I can take another dose and not realise that I am in trouble… 
cus my medication [insulin] it will kill you”. Robert’s emphasis of his dependence on others 
for life or death matters powerfully reflected a loss of agency, an individual’s capacity to 
exercise control over the nature and quality of one’s life (Bandura, 2001).  
In addition to depending on others, participants spoke about the need to rely on compensatory 
strategies to manage and cope with their everyday lives. Emily experienced this as neutral, 
saying “I make sure I write them [appointments] down, they’re very important”. In contrast, 
Matt (who is evidenced to show more ambivalence to accepting his memory difficulties) said 
“That [writing] makes it sound like there’s a problem [] you don’t write it down, that’s like 
saying it’s not right in the head”. Here he associated the strategy with incapacitation and 
making the problem more visible, rather than coping. The use of stigmatising language (‘not 
right in the head’) offered an insight into the difficulties he might be having in accepting there 
is a ‘problem’, again reflecting that Matt may be at a different stage in the process of sense-
making. In contrast Emily talked openly and consistently about her difficulties, actively 
pointing them out during the interview, saying “see that’s a memory thing, my mind just goes 
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blank”. Emily also showed more certainty regarding the aetiology, saying “‘I used to drink an 
awful lot and that damaged a lot of my memory []I’ve got Hepatitis C and you do lose your 
memory with that”. The impact of acceptance of the impairment on the process of coping is 
explored in the final theme. 
3.3.2 Negative feelings towards and about the self 
For all six participants, a loss of belief in their own abilities and an increased dependence were 
associated with negative thoughts and feelings. Four participants spoke about feelings of 
frustration as a result of cognitive difficulties. Emily said “[I can’t find my words] and it’s so 
frustrating”, and Jack said “[trying to concentrate] makes me angry, I show some physical 
signs you know”. Jack explained that the frustration can cause him to act out physically, “hitting 
my shoe”.  These comments all suggested a perception that they cannot do anything about their 
cognitive deficits, giving a sense they are not in control, which resultantly frustrated them. 
For some participants there was a sense that their cognitively impaired identity differed from 
their true identity, as James said “They’re gonna blame me [for missing appointments], no not 
me, it’s my memory but”. He highlighted a separation between himself and his memory and 
went on to explore his difficulty accepting what his impairment might say about his identity, 
exclaiming “I cannot have weakness you know what I mean, I am weak I am weak – 
impossible!” James’s awareness of his flaws impacted on his self-esteem as his deficits 
challenged his sense of self as competent. He later said “I’m thinking, I could, I’m sharp, but I 
know I am not, so this affects me”. In the first theme, James’ comment relating to a loss of self 
was further developed when he said “I was just a man who never turn up”. These statements 
suggested that James had lost a sense of who he was, instead defining himself in terms of the 
deficit. 
John also reflected on how the impairment challenged his view of himself and his abilities, 
saying “get very annoyed with myself, disappointed, very disappointed”. These feelings of 
24 
 
disappointment highlighted the contrast between his expectations and actual abilities, which 
was associated with negative feelings. Furthermore, Emily experienced memory difficulties in 
the interview and said “see what I mean I feel so stupid [] I get angry with myself [] it is very 
frustrating [] I criticise myself most of all because I should remember these things you know”. 
Other participants talked about feelings of depression associated with their difficulties. Jack 
said “I don’t feel good you know I don’t feel good”, and John said “It’s depressing it’s 
depressing it gets you down as well”. Feelings of low self-esteem and depression were reported 
in the above comments as participants compared what they can do with what they ‘should’ be 
able to do. Additionally, Robert said “But I do get frustrated with myself I give myself really a 
hard time, I call myself names, you’re so stupid you’re thick, you’re this you’re that”. He went 
on to say “and that [forgetting] just sends me into like a spiral of it [] get depressed, it’s not 
worth living”. Self-criticism featured heavily in participants’ accounts of their impairment as 
they attempted to deal with the discrepancy between how they are and how they want to be. 
Participants spoke about a vicious cycle of memory difficulties, negative feelings, self-
criticism, and low self-esteem. The use of negative labels and self-degradation further 
suggested that participants had internalised their impairment, seeing their difficulties as part of 
the self, for which they deserved to be punished. 
Interestingly, Robert and Emily were evidenced to confidently attribute the cause of their 
impairment to drug use and drinking, an example of self-infliction. This internal blame seemed 
to be associated heavily with self-criticism. In contrast, Jack assigned the cognitive impairment 
to external factors, including medication and trauma, which were through no fault or choice of 
his own. Jack instead said “my mind goes completely different way [] I don’t want to do [this] 
purposely”, suggesting a lack of self-criticism and self-blame. Matt spoke less about the impact 
of his impairment on his sense of self, as when questioned about the impact of forgetting on 
his feelings he said “I just don’t remember, that’s it!”. As outlined above, Matt may not have 
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perceived his difficulties to be particularly severe, and/or was in an earlier stage of awareness 
and acceptance of his impairment. This seemed to protect him from the potential negative 
consequences of acceptance on his self-esteem. 
Notably, Jack, James, Emily, John, and Robert all reported significant mental health 
difficulties, such as depression and anxiety. Difficulties described above regarding negative 
feelings about the self are factors commonly seen in depression and anxiety, and these mental 
health difficulties may have contributed to their tendency to respond to their impairment in a 
self-critical manner. Matt, who reported no mental health difficulties, did not express any 
negative feelings about the self. 
3.4 Coping with a lesser self 
3.4.1 Acceptance and adaptation 
Where individuals were in their process of accepting the cognitive impairment varied across 
the group. Matt expressed ambivalence towards accepting whether there was a problem, saying 
“I think everyone has it [memory difficulties] but sometimes it’s like, I dunno, I dunno, maybe 
I put it down to the drinking”. Matt had not been able to consider the process of adaptation to 
an impairment he had not yet accepted, saying “Why do you need to write things down to make 
you remember, you don’t write things down to remember, you say ‘oh I’m gonna remember 
that and you remember’, and if you don’t you’ve forgotten”. This comment highlighted his 
perception of memory as a simple task, controlled largely by will. As a result Matt was unable 
to talk any further about possible compensatory strategies to manage memory difficulties. 
The five other participants showed greater acceptance of their cognitive difficulties. Although 
for some this had a negative impact on their feelings about the self, as outlined in the second 
theme, it also enabled participants to face up to the impairment and consider the use of 
compensatory strategies. John said “I do [write lists] now I do a lot now, I never used to, cus 
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obviously I didn’t realise how bad my memory was getting”. Here he commented on the process 
of awareness and acceptance of the difficulties being a necessary precursor to adaptation. He 
went on to say “I’ve learnt to cope and adjust and yeah I write notes [] especially for 
appointments [] I have texts on my phone I keep going over the texts”.  John talked about the 
changes he has made to support his memory which included visual reminders and rehearsal of 
information.  
In contrast James talked about his dependence on his recovery worker to remind him of 
appointments, saying “yes [he helps me] with like dates and things [] he makes sure I turn up”. 
The importance of a valued person to support the cognitive impairment was prevalent for five 
participants. They offered insight into what factors contributed to support being experienced 
as positive and helpful. James emphasised the importance of a trusting relationship with his 
recovery worker, saying “the only man I trust for real is him [recovery worker] [] he don’t 
give up on me”. This comment highlighted that James had no other trusting relationships in his 
life, and the importance of feeling cared for was a significant motivating factor to remain 
engaged in treatment, as he went on to say “I try and keep myself going because I don’t want 
to let [name of recovery worker] down because he’s done so much”. In contrast Robert talked 
about his lack of trust in professionals, “people still don’t care enough though [] they don’t 
ring me up and go ‘we’re just wondering how you are we haven’t seen you’”, and it seemed 
this consequently impacted his willingness to engage with more support, contradictorily saying 
“I just find it an intrusion [] I don’t want another thing [] I’ve got enough”. These comments 
highlighted the importance of building a positive relationship to support treatment engagement.  
Another important finding emerged whilst talking about support in the form of text message 
appointment reminders, as three participants commented on their shortcomings. John said 
“they’ll send me a message saying your appointment is due in an hour or something, they’re 
good, but your appointments due in two weeks, that ain’t no good for me really, actually asking 
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you to remember something for two weeks is difficult”. Similarly, Robert said “sometimes the 
chemist will tell me ‘in two days times it’s [opiate prescription] going to run out’ but they don’t 
normally tell me until the day its run out, so the day it’s ran out, I know I’ve missed my 
appointment”. These comments evidenced the importance of well-timed appointment 
reminders, suggesting that if they were too far in advance they would be forgotten.  
A poignant moment in all interviews was when participants spoke about what other support 
would be helpful. Five participants shared that they found talking in the interview particularly 
therapeutic. James said “I need to talk man I need to get this out”. Further comments suggested 
that participants felt there was not enough support available to them, as Jack said “I don’t think 
[there is enough support], except for psychiatrist I don’t see any different help”. Comments 
were made which suggested that participants resorted to maladaptive coping strategies due to 
a lack of awareness or access to more helpful strategies. Robert said “That’s [drug use] the 
only way I know how to cope”, and John said “I’m not sure what they [professionals] could to 
do help, I don’t know, hmmm, not really no, not that I know of”. There was a widespread sense 
across participants that little support was available, and this further manifested in a sense of 
helplessness as participants did not actually know what might help.  
3.4.2 Familiar but maladaptive coping strategies 
Avoidance was a major maladaptive coping strategy spoken about by all participants. Jack and 
James talked about avoiding contact with people and the outside world. Jack said “I stopped to 
go visit nobody, I don’t want nobody come to visit me because it [] upsetting people” and James 
said “I have to run away from relationships [] avoid questions, avoid things people ask me 
stupid questions [] this only gets you closer”. Jack expressed his desire to hide away to avoid 
upsetting anybody, whereas James focused on the negative impact that others have on him. 
Later James reflected on avoiding being ‘part of the problem’, as he recognised these patterns 
of avoidance were perpetuating the problem and preventing him from moving forward. A gap 
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between one’s ideal self and one’s actual self were evidenced in the second theme for both 
James and Jack. Research suggests this is associated with feelings of depression and low self-
esteem (Higgins et al., 1985). Interestingly, both James and Jack reported significant levels of 
anxiety/panic and depression, of which avoidance is a common symptom.  
Participants also spoke about avoiding thoughts, feelings, and experiences as a way of coping. 
Robert said “I don’t wanna remember things [] there were great big parts of my years missing, 
because I don’t wanna go there”. Here Robert expressed that forgetting can have a protective 
function, distinguishing between the usefulness of forgetting past traumatic memories, and the 
deficit of forgetting more recent experiences. However Robert also talked about the need to 
avoid and forget the present, when he is feeling overwhelmed by his impairment, saying “too 
many things, too many things [] I hit the fuck it button then, fuck the appointments, fuck the 
medication, I can’t be bothered with it, it’s too much aggravation, it’s too much pressure on 
me. And that can be bad for me. [] The more appointments I’ve got the easier it is for me to 
just go ‘pfft forget it’.” This comment emphasised how challenging trying to cope ‘adaptively’ 
can be. When the demand is too high Robert resorted to giving up and giving in, and would 
often use drugs to support this process, saying “Opiates is the kind of drug that enables you to 
just let go of all that stuff [] there’s nothing for me to remember”. However Robert recognised 
“that can be bad for me” as it sets him back in his journey to recovery from addiction, and in 
effectively managing his cognitive impairment. Other participants also talked about using 
opiates as a way of coping, enabling the person to avoid difficult feelings and escape reality. 
John said “I use drugs normally to cope [with difficult feelings], there’s a pattern definitely”. 
Robert further reflected on the vicious cycle caused by the memory impairment and 
maladaptive coping strategies, saying “it’s a vicious circle, it’s hard to pull myself out of that 
[] most of the time I use [] I don’t have to think about nothing do I, that just takes it all away”. 
An area for further exploration would be to explore participant experiences following drug use, 
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and whether this further impacts their perceived cognitive impairment and sense of self. 
However Robert offered insight into the importance of drug use, saying “Because I tell you it’s 
a big coping mechanism for people [] if that wasn’t there, I wouldn’t be sitting here talking to 
you now”. Although in the first theme Robert was clear that he believed drugs were a major 
cause of the cognitive impairment, here he clarified they are in fact keeping him alive; 
suggesting it is better to be alive with impairment, than not here at all.  
4. Discussion 
The findings from the current study will be re-examined in light of the existing theories and 
research in comparable fields. Implications of the findings for clinical practice will be explored. 
Finally methodological limitations are discussed. 
4.1 Summary of findings and existing theory 
Using an interpretative approach, this study investigated the individual experiences of long 
term opiate-users attending a drug and alcohol service for opiate-substitution, who self-
reported memory and thinking difficulties. The group reflected a typical sample of opiate-users 
(PHE, 2017a), as they reported a range of co-morbid mental health diagnoses, concurrent 
polydrug and alcohol use, health conditions, and use of prescribed medications. Although all 
participants reported deficits in some regard, individuals varied in the extent to which they had 
made sense of their experiences, how it impacted their sense of self, and how they coped.  
The data suggested that participants attributed their difficulties to a range of causes including 
drug abuse, alcohol use, trauma, medication, and head injury, reflecting the complexity of 
cognitive impairment in long term opiate-users. These experiences fit with existing research 
which suggests that impairment is mediated by factors such as concomitant alcohol abuse and 
head injury (Darke et al., 2000). Participants who attributed their impairment to the drug use 
referred to it as self-inflicted, placing the blame and locus of control internally. In some cases 
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this was associated with high levels of self-criticism and low self-esteem. For others who 
attributed the impairment to external factors such as trauma and medication, the level of self-
criticism appeared less severe, although feelings such as low mood and depression were 
reported. The current data suggest that participants’ co-morbid mental health difficulties were 
associated with certain styles of coping; for example people experiencing depression and 
anxiety reported low self-esteem and self-criticism in response to their cognitive difficulties.  
Existing research indicates that even mild memory changes can result in meaningful impacts 
on everyday life (Preeyam et al., 2016). Their study suggests that emotional reactions to 
memory failures, such as embarrassment and frustration, is associated with the use of 
compensatory memory strategies. This was comparable to the current study which found that 
participants who were most disturbed by their memory impairment were more likely to 
compensate. Evidence shows that psycho-educational approaches to support people with mild-
cognitive impairment is of benefit, through normalising memory changes and increasing 
feelings of control over their memory (Wiegand et al., 2013). These suggestions are supported 
by theory which states that locus of control and self-efficacy contribute to behavioural control 
(Ajzen, 2002). Sharing knowledge about memory changes and supporting the current 
participants to manage negative emotions and self-evaluations may also be of benefit. 
Leventhal’s self-regulation theory posits that the way in which an individual perceives their 
problem, known as illness representation, influences the related emotions, emphasising the link 
between cognitive and emotional processing (Leventhal & Ian, 2012). For example, denial may 
reduce illness perception and as a result decrease negative emotions. This seemed relevant for 
one participant who had not yet accepted the extent of his difficulties, and reported few negative 
emotions. In contrast, participants who had accepted their impairment were familiar with a 
range of negative emotions including disappointment, self-blame, and depression. Another 
factor contributing to an individual’s illness representation is the extent to which they believe 
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their difficulties can be controlled or improved. This has been shown to be an important 
determinant of behaviour (Petrie & Weinman, 1997; Weinman et al., 2000). The participants’ 
experience of uncontrollability and inevitability about their memory difficulties could 
resultantly influence their motivation to engage in treatment (Cooper et al., 1999) and utilise 
compensatory strategies. Notably, all participants in the study had been struggling to achieve 
drug abstinence for a minimum of five years. An individual with low self-efficacy and agency 
might feel disempowered towards making any changes. Illness representation theory has also 
been usefully applied in existing qualitative research exploring the experience of mild cognitive 
impairment (Lingler et al., 2006). They highlight the need for further research investigating the 
link between illness representation and health behaviours in cases where the illness trajectory 
is uncertain, the impact on daily life is less evident, treatment remains elusive, and individuals 
may be subject to additional threats to well-being; as is the case for people with mild cognitive 
impairment and drug-users. Furthermore, the impact of co-morbid depression on illness 
representation and health behaviours is an important area for future research. Current findings 
suggest depression is associated with significantly worse health outcomes, which can often be 
explained by behavioural factors (Whooley et al., 2008). 
Nonetheless the data did suggest that participants who had accepted their difficulties were 
better able to engage in compensatory strategies. For example one participant who had 
involvement from a memory service following a head injury, showed acceptance of his 
impairment and used helpful compensatory strategies such as memory aids and dosette boxes. 
However in this study, recognition of memory problems did not lead to better coping per se, as 
participants also reported using illicit drug to cope with the emotional impact of the cognitive 
impairment, as well as the stress associated with daily life. This resulted in a conflict for 
participants who were in treatment for drug addiction working towards abstinence. Leventhal’s 
self-regulation theory highlights the importance of the environment around an individual 
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(Leventhal & Ian, 2012). Coping strategies are limited by what the individual knows and what 
is available. Participants in this study reflected on the lack of support available, in particular 
regarding their cognitive impairment, and one participant talked about drug use as his only way 
of knowing how to cope. 
Participants’ emotional experiences had a powerful effect on how an individual coped with 
their cognitive impairment. Self-discrepancy theory suggests that the gap between an 
individual’s actual self and their ideal can result in emotional discomfort (Higgins et al., 1985). 
A number of participants reflected on this discrepancy and spoke about feelings of 
disappointment and frustration, in line with the theory. The theory posits that when one’s actual 
self does not match another’s hopes or wishes, people are vulnerable to shame and 
embarrassment. In these instances, participants in the current study reported a desire to avoid 
contact with others which makes sense in light of their perceived rejection from others. 
Furthermore, a discrepancy between one’s actual self and their expectations of what they ought 
to be can be associated with agitation-related emotions such as self-dissatisfaction. Again it 
was clear that for participants who shared a sense of what they ‘should’ be able to do also 
showed a readiness for self-criticism and self-punishment. Comparable research exploring the 
subjective experience of cognitive impairment in people with epilepsy, indicated the presence 
of a pre and post injury discrepancy in one’s abilities, and the resultant impact on an 
individual’s sense of wellbeing, and furthermore their coping (Di Battista et al., 2014). They 
concluded that exploring mood and signs of maladaptive coping could help clinicians support 
individuals in working towards a more adaptive recovery trajectory. It is possible that exploring 
these factors with opiate-dependent individuals with cognitive impairment could also support 
recovery. Furthermore, in the current study, participants valued the opportunity to share their 
difficult emotional experiences during the interview, and such opportunities might further 
support individuals in their recovery from addiction and adaptation to cognitive impairment. 
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4.2 Clinical Implications 
These findings, together with existing theory, can be used to develop suggestions for clinical 
practice. Leventhal’s self-regulation model states that illness perception can be improved by 
increasing understanding about the difficulties (Leventhal & Ian, 2012). Actively offering 
service-users an opportunity to talk about memory and thinking difficulties might improve 
awareness and acceptance, and reduce stigma. The ‘memory management’ hand-out (appendix 
6) offered to participants in this study could be utilised across the service to improve service-
users awareness of such difficulties, and possible ways to manage. This might increase an 
individual’s sense of self-efficacy and controllability over such difficulties. However the 
current data suggest that an individual’s level of acceptance of their difficulties might impact 
whether such a resource is experienced as necessary and helpful. 
There is extensive research outlining the positive effects of improved self-efficacy and agency 
on behavior change (Bandura, 1977; 2001, Holloway & Watson, 2002). Individuals with a 
stronger sense of control over their symptoms, and stronger beliefs in their abilities to manage 
such symptoms, feel more motivated to implement positive changes. Strategies such as 
problem solving and SMART goals can improve an individual’s self-efficacy (Skinner et al., 
2003), and could be utilized in drug and alcohol services to support an individual in working 
towards challenging goals. It will also be important to consider the impact of any co-morbid 
mental health difficulties on health behaviours, and people may need treatment for such 
difficulties if they become a barrier to drug abstinence. 
Recognising the presence of cognitive difficulties in an individual’s formulation is integral to 
support the appropriate and effective management of someone in treatment for an opiate-
dependency. Tailored intervention programmes could target specific needs for those who 
experience cognitive impairment in order to maximise functional outcomes. The recent Clinical 
Management Guidelines state that simple strategies should be used to support engagement, for 
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example texting in advance (DoH, 2017). This study highlighted the importance of such 
strategies taking into account an individual’s impairment, for example well-timed appointment 
reminders which support a person’s memory difficulties. Furthermore, participants emphasised 
the importance of positive relationships with professionals, and in some cases were directly 
linked with an individual’s treatment engagement.  
Noticeably, participants focused mainly on memory difficulties when sharing their experiences 
of cognitive impairment. Participants might have had difficulty considering other ‘thinking’ 
difficulties, or perhaps such difficulties were outside an individual’s awareness. Although some 
participants talked about difficulties with attention, other executive functions such as poor 
problem solving and impulsivity were rarely considered, yet may exist outside of the person’s 
awareness. Future research needs to focus on the impact of deficits other than memory and 
attention. 
4. 3 Limitations of Methodology 
There are limitations associated with IPA methodology. Unavoidably, the researcher will have 
interpreted the data through the lens of their pre-existing knowledge, which included previous 
life experience of the topic, and knowledge of certain theoretical frameworks (Willig, 2001). 
However the provision of verbatim quotes in the report invites readers to assess the researcher’s 
interpretations for themselves. Additionally, adherence to Yardley’s (2000) guidelines 
improved the study’s validity and reliability (appendix 11). The researcher also considered the 
influence of their potential biases throughout the study through keeping a reflective journal 
(appendix 12). Credibility checks were done at multiple different time points to enable other 
researcher’s to explore the analysis process and challenge the results (appendix 13-14).  
Another inherent limitation was associated with the role of language in conveying meaning. In 
this study the researcher assumed a common and shared understanding of constructs such as 
‘memory and thinking difficulties’, rather than viewing it as purely constructed through social 
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experiences and language (Ormston et al., 2014). Participants may have had their own varied 
and personal understandings of such constructs. Language may have been understood 
subjectively by participants, and their interpretation and language understood subjectively by 
the researcher. This offers many opportunities for a deviation in the intended meaning between 
researcher and participant (Willig, 2001). Where appropriate, the interviewer would check their 
understanding with the participant, in the attempt to make miscommunications known. It is 
important to consider that self-awareness of memory and thinking difficulties may be part of 
everyone’s normal life, not just for people with cognitive deficits. Further research needs to 
include objective measures of everyday functioning problems, such as an ‘Activities of Daily 
Living’ scale, or a quality of life measure (Lawton & Brody, 1969). 
Across qualitative research, a sample size of six could be considered small and seen to impact 
the generalisability of the findings. However such a small sample size is asserted by IPA, and 
was necessary to ensure sufficiently detailed analysis and reporting of each participant’s 
interview, to adequately reflect their nuanced subjective experiences (Smith & Osborn, 2008).  
Nonetheless, findings and conclusions have been stated cautiously and are to be interpreted 
with care, given the highly specific nature of the participant group. 
Participants in this study were required to self-identify memory and thinking difficulties. 
Consequently, presence of true cognitive impairment, as defined by scores on valid and reliable 
psychometric tests, must not be assumed. Participants’ subjective experiences of impairment 
may be qualitatively different from those defined by psychometric measures. Furthermore 
participants might have minimised or maximised their impairment due to factors such as insight 
and awareness, shame, or help-seeking. Notwithstanding, this study highlighted that 
individuals’ experiences of cognitive impairment were meaningful, impacting their wellbeing 
and influencing their coping strategies. Furthermore, a lack of formal diagnosis of cognitive 
impairment more accurately reflects the experience of people attending drug and alcohol 
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services. Self-reports of cognitive difficulties should therefore be taken seriously and 
responded to appropriately. 
Participants were offered a monetary incentive to take part in the study which could have 
resulted in a selection bias. Still, it was necessary to increase motivation to take part, as 
recruitment to the study was particularly challenging. As most participants were referred by 
their recovery worker it reduced the likelihood that participants self-selected themselves solely 
for the monetary gain.  
Although participants reflected a relatively homogenous group of chronic opiate-users, 
individual differences were noted. For example two participants reported experiences of 
significant head injuries, some were using illicit drugs ongoing, whereas others were in 
abstinence outside of the prescribed opiate-substitution. These factors could have impacted 
their level of cognitive impairment, and further impacted their approach to making sense of 
and coping with the impairment. Such contextual factors were considered throughout the 
analysis to highlight possible hypotheses for individual differences.  
A larger study employing mixed methodologies would be beneficial to further substantiate this 
study’s findings. Participants could be assessed for cognitive impairment using valid 
psychometric tests, prior to qualitative interviews. However, it remains important for 
individuals who self-report cognitive difficulties to be recognised, as existing research 
emphasises the meaning of impairment for the individual, not the severity of the deficit per se 
(Howes et al., 2005). 
4.4 Conclusions 
This study is the first of its kind to investigate the subjective experience of cognitive 
impairment in a group of individuals with long-term opiate dependencies. Findings suggest 
these individuals’ experience and manage their difficulties in a variety of ways. The difficulties 
can have a widespread impact on an individual’s daily functioning, resulting in an increased 
37 
 
dependence on other people and strategies, and negative feelings about the self. Findings 
suggest that services must pay more attention to the impact of cognitive impairment on 
treatment engagement in addiction services. This is in line with suggestions made in the recent 
2017 Guidelines on Clinical Management, which suggests drug services should screen for 
cognitive impairment and make necessary adaptions, such as shorter sessions and involving 
family (DoH, 2017). Unfortunately, the vast majority of treatment services for drug addiction 
do not have access to specialist psychiatry or clinical psychology, and therefore it may be 
assumed that cognitive deficits are not commonly assessed or taken account of in interventions 
(Davis et al., 2016).  
The current results highlighted a range of clinical implications which could provide people 
with more support, for example, well-timed appointment reminders to support memory 
difficulties, and strategies such as problem solving and goal setting to support people’s efficacy 
in working towards recovery. People might also benefit from the opportunity to talk about the 
emotional impact of their impairment and the possible barriers to recovery. Such interventions 
might improve treatment engagement and completion for opiate-dependent individuals, which 
is currently at an all-time low of 26% (PHE, 2017b). 
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Appendix 3. Participant Information Sheet 
 
Participant Information Sheet [08.03.2017, Version 3] 
EXPLORING MEMORY AND THINKING DIFFICULTIES IN OPIATE-USERS 
IRAS ID:  
Introduction 
I am a trainee clinical psychologist. This study is part of my doctoral degree and I am 
supervised by x at the University of Surrey and x at the service. 
I would like to invite you to take part in a research project. Before you decide whether 
or not to take part, I would like you to understand why the research is being done and 
what it will involve for you. Please take the time to read the following information 
carefully. Talk to others about the study if you wish. If we meet, I will also go through 
this information sheet with you and answer any questions you have. Please ask if 
anything is not clear. 
What is the purpose of the study? 
People who have been given a diagnosis of opiate-use disorder sometimes 
experience thinking difficulties. For example, difficulty with remembering things, 
concentrating, planning for tasks and activities, doing several things at once, or 
switching from one activity to another. This study aims to understand this experience 
better. I am interested in interviewing people about their experiences of thinking 
difficulties. I hope this will study will produce knowledge that can be used to improve 
future services people receive and guide future research. 
Why have I been invited to take part in the study? 
You have been invited to take part in this study because you have been given a 
diagnosis of opiate dependence disorder and are receiving treatment at x. You have 
seen the advertising poster and contacted me, or a member of the NHS team thought 
you might be interested in this study’s focus on thinking difficulties (difficulty with 
remembering things, concentrating, planning for tasks and activities, doing several 
things at once, or switching from one activity to another). I will be interviewing a 
maximum of 8 people about their experiences. 
Do I have to take part? 
Participation is voluntary. It is up to you whether or not to join the study. After we have 
discussed the information sheet, and you have asked any questions, you will be given 
up to 4 weeks to decide whether to take part. If you agree to take part I will then ask 
you to sign a consent form before completing the study. You are free to withdraw from 
the study at any time, without giving a reason. This would not affect the standard of 
care you receive. 
What will my involvement require? 
If you agree to take part I will first ask you for some examples of your thinking 
difficulties. This could be done at the x, over the phone or by email, and will take 
roughly 10 minutes. If you have the kinds of thinking difficulties this study is 
interested in, we will then arrange a time and date to meet that suits you best. We 
will meet in a room at x, and we will meet for between 45 minutes and 1 hour to 
complete the interview. 
Interview: First we will ask you some basic questions about yourself, for example 
how many years you have had in education, and your current living circumstances. 
Then we will ask questions about your experience of thinking difficulties, for 
example, what you notice, what’s hard/easy, what do they get in the way of. 
However we hope this will take the form of a conversation and that you will free to 
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talk. This will take between 45 minutes and 1 hour, and you will be able to take 
breaks if you need to. This interview will be audio-recorded. 
At the end of the interview, you will be given a £10 store voucher for an agreed outlet 
store. If you begin the interview but do not complete it, you will be given a £5 store 
voucher instead. We can send you a copy of the results of the study when the 
project is finished. If you would be happy to share your thoughts about these results, 
please let us know. 
The researcher will also access your clinical records at x to gather demographic 
information, for example, your diagnoses and prescriptions. 
What will I have to do? 
All meetings will take place at x. If you would like to take part I will first ask you for 
some examples of your thinking difficulties. If you have the kinds of thinking difficulties 
this study is interested in, then we can arrange a time and date meet and complete 
the interview. I can answer any questions you have about this. You will need to travel 
to x to meet with me and complete the interview. 
What are the possible disadvantages or risks of taking part? 
It is possible that during the interview you may find yourself talking about something 
that brings up difficult feelings. If this happens, we can decide whether you want to 
take a break, stop, or talk about something different. The researcher will do their best 
to help you with these feelings at the time. You can contact your recovery worker, or I 
can contact them on your behalf, if you experience ongoing distress. 
What are the possible benefits of taking part? 
No clinical benefit is intended by taking part, but I hope you will have a positive time 
sharing your experiences with me. I hope the information I get from this study will help 
improve the support offered to people with substance misuse difficulties. 
What happens if I don’t want to carry on with the study? 
If you withdraw from the study up to two weeks after the interview, we will not use any 
data collected in the final analysis and we can destroy the data collected so far, if you 
wish. Unfortunately after this two week period, data will be used in analysis and 
therefore we would not be able to remove it from the study. 
What happens when the research study stops? 
All data collected will be stored anonymously and securely for 10 years at University 
of Surrey. This is in accordance with the University of Surrey policies. You can opt to 
receive a summary of the results when I finish the study and you can comment on 
these if you want to. If you would like a copy of the results I will need to retain some 
personal identifiable information (name, forwarding address/email). This information 
will be kept securely on an encrypted USB at the University of Surrey and will be used 
only for the purpose of sending you a summary of the results of the study. Only 
members of the research team will have access to this information. This information 
will be deleted once I have sent you the results. It may take up to 2 years after you 
participate in the research for you to receive the results. 
What if there is a problem? 
If you have any concerns about any part of this study, you can contact me and I will 
do my best to answer your questions (Telephone – please leave a message and I will 
return your call). You can also talk to your recovery worker. For further advice you can 
talk to a member of the Patient Advice and Liaison Service (PALS) on x. If the problem 
is not resolved, you can contact the head of school at University of Surrey, Derek 
Moore on 01483686933. 
Will my taking part in the study be kept confidential? 
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Your recovery worker will know that you are taking part in this study. However they will 
not know about the content of the interview, unless during the course of the interview 
you say something that causes me to be concerned for your safety or the safety of 
others, or that you might be breaking the law. I will then need to inform your recovery 
worker immediately, and I will let you know if I have to do this.  
Audio-recordings of interviews will be saved anonymously and securely. The 
recordings will then be transcribed into written notes by the chief investigator. A 
professional transcriber may be used if you provide consent for this. All names will be 
changed and identifying information will be removed from these written versions. The 
professional transcriber will be required to sign a confidentiality agreement to ensure 
information in the recording remains confidential. Once transcription is completed the 
professional transcriber will be required to delete their copies of the written 
transcription and the audio-recording file. The transcriber will be required to act in 
accordance with Data Protection Act 1998, maintain confidentiality and store data 
securely and anonymously. Only myself, my supervisors, and you will have access to 
the audio-recordings and written interviews after transcription.  
Your words may be quoted in the final write-up of the study and future publications. 
However, every care will be taken to ensure these quotations are anonymous. 
All of the information will be stored securely for 10 years at University of Surrey. Data 
will be stored securely in accordance with the Data Protection Act 1998. 
What will happen to the results of the research study? 
The results will be written up as a doctoral thesis. They will also be submitted for 
publication in a peer reviewed journal and may be presented at academic conferences. 
You will not be identified in any report or publication, although your words may be 
quoted anonymously. 
Who is organising and funding the research? 
The study is being internally funded by University of Surrey. The project is supervised 
by x at the University of Surrey, and x at x. 
Who has reviewed the project? 
All research in the NHS is looked at by an independent group of people called the 
Health Research Authority, to protect your interests. This study has been approved 
and given a favourable opinion by South Central-Berkshire Research Ethics 
Committee. 
 
Contact details of researchers 
For further information about the study and taking part please contact: 
Sophie Bates: x (call backs will be given); or x 
You may also contact x, project supervisor at University of Surrey on x or x. 
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Appendix 4. Consent Form 
 
Consent Form [08.03.2017, Version 3] 
 
EXPLORING MEMORY AND THINKING DIFFICULTIES IN OPIATE-USERS 
IRAS ID:  
 
  Please initial each box                           
 
 I have read and understood the Information Sheet provided (version 3, date 
08.03.17).  I have been given a full explanation by the investigators of the nature, 
purpose, location and likely duration of the study, and of what I will be expected 
to do.   
 
 I have been advised about any disadvantages and risks on my well-being which 
may result.  I have been given the opportunity to ask questions on all aspects of 
the study and have understood the advice and information given as a result.                                                                                       
                       
 I agree to take part in a one-off interview to explore my experiences of thinking 
difficulties.  
 
 I agree for the interview to be audio recorded and transcribed for the purpose of 
this study. 
 
 I understand and agree that the recording will be transcribed into a written copy 
by a professional transcriber and all information will be recorded anonymously. 
The professional transcriber will be required to sign a non-disclosure agreement 
to ensure the information in your recording remains confidential. The transcriber 
will delete all written copies of the transcription and the audio-recording file when 
transcription is completed.  
 
 Only members of the research team will have access to the original recording 
and written copy after transcription. I understand that this recording and written 
copy will be saved with an anonymous code and held securely at University of 
Surrey for 10 years. I retain the right to ask for the tape to be destroyed up to 2 
weeks after the interview, in which case my data will not be included in the study. 
 
 I agree for my anonymised data collected in the interview to be used for this 
study. 
 
 I agree for my anonymised data collected in the interview to be used for future 
research.  
  
 I give consent to my words being anonymously quoted in written reports. 
 
 
 
 
 
 
 
 
Yes No 
Yes No 
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 I understand that all project data will be held for at least 6 years and all research 
data for at least 10 years in accordance with University policy and that my 
personal data is held and processed in the strictest confidence, and in 
accordance with the UK Data Protection Act (1998). 
 
 I give permission for the principal investigator to access my clinical records and 
relevant sections of my medical notes at x for the purpose of this study. 
 
 I agree for the researchers to contact me to provide me with a study results 
summary. 
 
 I understand that I am free to withdraw from the interview at any time without 
needing to justify my decision, without prejudice and without my legal rights and 
care being affected.  
 
 I understand that I can request for my data to be withdrawn up to 2 weeks after 
the interview and that following my request all data already collected from me 
will be destroyed and not included in the study. 
 
 I agree for the researcher to contact my recovery worker if she has any concerns 
for my safety or the safety of others. I understand that she will inform me if she 
needs to do this. 
 
 I acknowledge that in consideration for completing the study I shall receive a 
£10 store voucher as compensation for my time and inconvenience and I 
recognise that the sum would be £5 if I withdraw before completion of the 
interview. 
 
 I confirm that I have read and understood the above and freely consent to 
participating in this study.  I have been given adequate time to consider my 
participation. 
 
 I acknowledge that I will receive one copy of the consent form, one copy will be 
kept by the research team, and one copy will be kept with my medical records 
at x. 
 
 
 
 
Name of participant (BLOCK CAPITALS)   
 ......................................................  
 
Signed 
 ......................................................  
 
 
 
 
 
 
 
 
Yes No 
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Date 
 ......................................................  
  
                                                         
Name of researcher  …….............................................. 
(BLOCK CAPITALS)   
  
Signed  .................................................... 
 
Date 
 ………………………………………………..                                                         
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Appendix 5. Interview Schedule 
 
Interview Schedule – Version I (22.05.17) 
 
Demographic Information 
Gender: 
DoB: 
Ethnicity: 
School leaving age: 
Living circumstances: 
Partnership status: 
Employment: 
Length of opiate-use: 
Length of time in contact with drug and alcohol services: 
Medications (name, dose, how long): 
Other drug previous and current drug use and length: 
Mental health diagnoses: 
Interview 
1. Experiences of cognitive difficulties 
a. What makes you think you have memory and thinking difficulties? When did you 
first notice them? 
b. What kinds of memory and thinking difficulties do you have?/ Can you give me 
some examples? 
i. Provide concrete examples if necessary i.e. some people find it hard to 
remember what someone said….some people find it hard to do several 
things at once…..some people find it hard to organise their money. Is that 
the same/different for you? 
Prompts: -  
Can you give me an example of..... (whatever difficulty mentioned)? –  
Can you tell me about a recent time when....? –  
What happened?  
How did you feel? (emotions – sad, frustrated, angry, embarrassed) 
What did you do in response?  
Can you tell me what it is like when...?  
 
2.  Impact on life 
a. How do they (memory and thinking difficulties) affect your day?  
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i. Provide concrete examples if necessary, i.e. paying your bills, arranging to 
see friends, coming to see your recovery worker, going to appointments, 
shopping, cooking 
ii. Can you tell me about a recent time when x happened? 
b. How would things be different if you didn’t have these difficulties? 
c. What would be normal for you? 
i. What was life like before you had these difficulties? 
Prompts: 
 How does it make you feel? How do you feel after…? 
 What do you think when that happens? 
 How do you respond? 
 Can you tell me what it is like when….? / What’s that like for you? 
3.  Attribution/understanding 
a. What do you think has caused these difficulties?/ How do you explain these 
difficulties, what caused them, where did they come from? 
b. How long have you had these difficulties? What was happening at the time? 
c. Are there any other reasons you may have these difficulties? 
i. Has anyone ever told you why you might have them? What do you think 
about that? 
Prompts:  
What was going on in your life when they started?  
How does it make you feel?... have you always felt that way about the 
difficulties?  
 
4. Feelings about self – if not already covered.  
a. You’ve mentioned x, x and x - I wondered if you could tell me a bit more about 
how it makes you feel when....? /how does x make you feel? 
b. Has it changed how you feel about yourself? 
i. Concrete example e.g. how does it make you feel when you forget an 
appointment?  
ii. How do you feel when it is particularly good/bad? 
5. Others 
a. Do other people notice these difficulties? What have they said to you? How do 
they react? 
i. friends, family, psychiatrist, recovery worker, people you don’t know 
b. Does it affect your relationship with them? 
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i. Does it affect whether you want to see them, what you share with them, or 
how you talk with them? 
ii. Are they supportive? Do they say anything about them? – Give examples 
Prompts: 
How does it make you feel? 
How do you respond? 
What do you say? 
What do you think? 
Can you tell me what it is like when….? 
 
6. Coping (idea of interviewees as experts, naturally occurring therapeutic strategies) 
a. We’ve talked about xxxxx – what do you do? how do you cope with xxxxxx? 
b. Is there anything that helps you manage these memory and thinking difficulties? 
Who helps? Can you describe a recent example? (supportive people, strategies etc) 
c. What makes xxxxx better?  
d. Is there anything you find unhelpful? What makes xxxxx worse?  
e. Do you do anything differently because of these difficulties? How do you feel 
about this? 
Prompts 
 Can you tell me what that is like? 
 What is it like when….? 
 How does it make you feel? 
 How do you respond?  
 
7.  Help that’s available 
 
a. Do you know whether there’s any help available?  
b. Does your care coordinator/family/friend etc think that there‘s any help available? 
c. Is there anything that might help? Is this available?  
Prompts 
 Can you tell me what that is like? How does it feel? 
 How do you respond? 
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Appendix 6. Memory Management Strategies  
 
Memory Management Tips 
 
BE KIND TO YOURSELF 
 Try to avoid stressful situations – anxiety and tiredness can make it 
harder to remember things 
 Try not to do too many things at the same time 
 Reduce distractions in your environment such as background noise 
 If you do forget something, try and stay calm and think of links that may 
jog your memory 
ORGANISATION 
 Routine, routine, routine – doing set activities at set times of the day 
 Keep things tidy and organised – have a set place for certain things, and 
always put things back in the same place 
CONCENTRATION 
 Focus on one thing at a time and don’t let yourself become distracted 
 Finish one task before moving on to the next 
 If you have to do something, do it straight away, so that you don’t forget 
it later 
 Have regular breaks to avoid overload and tiredness 
 Repeat things in your mind to help you remember – for example names, 
places, dates 
MEMORY AIDS 
 Chalkboards / Whiteboards – write down to-do lists for each day and 
cross things off when they have been done 
 Diaries, calendars 
 Notepads, post-it notes 
 Alarms, mobile phones 
 Other people – friends and family 
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Appendix 7.  Ethical Approval: Health Research Authority 
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Appendix 9. R&D Expression of Interest Form 
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Appendix 10. Process of analysis 
 
Single-case analysis 
On first reading of the transcript, initial responses and thoughts about the data were made in 
one column, including any associations or connections, or notes of significance. The 
transcripts were then re-read and the initial responses were translated into emergent themes in 
another margin. Emergent themes were of a higher more abstract order, and aimed to capture 
the essence of what had been said by the participant. 
Identification of emergent themes 
Identifying emergent themes for each case was an iterative process. Identifying superordinate 
themes across participants was a further iterative process. Themes were selected on their 
relevance to the research question, richness of the material, and the level of importance for 
the participant. Interpretations were continually checked to ensure they reflected the 
participants’ actual words, and a number of themes and interpretations were dropped along 
the process, as they lacked credibility. 
Alterations made to improve readability of extracts 
Square brackets represent missing material and were used to ensure the inclusion of relevant 
information and to make the quotes more manageable sizes. Information within square 
brackets indicates added material which clarifies what a participant is referring to. Dotted 
lines indicates a pause in the participants’ parlance. Minor hesitations and utterances 
(“umms”) have been removed when they are not considered to impact the meaning.  
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Appendix 11. Yardley’s framework: ensuring quality and validity 
Sensitivity to context 
The literature review outlined existing quantitative data in the area of cognitive impairment, 
whilst highlighting a lack of qualitative research relating to cognitive impairment and 
substance misuse. Further information from Public Health England and Department of Health 
documents highlighted the importance of carrying out such research and its potential impact 
on clinical contexts. The researcher remained sensitive to the participants’ experience of 
sharing personal information, using a non-judgmental, empathic, and validating response. 
Data was analysed in-depth and the voice of each participant was represented using verbatim 
extracts. 
Commitment and rigour 
I showed commitment to the research by immersing myself in the topic, including reading 
published literature in scientific journals, keeping up to date with current affairs in the area 
(news stories, public health, policies etc), watching documentaries about the participant 
group, and meeting with current or abstinent drug-users outside of the research study and 
service environment. I chose to complete all transcriptions to further immerse myself in the 
data and support the process of in-depth analysis. As a beginner I was motivated to utilise 
every opportunity for further teaching and supervision in qualitative and IPA methods. I 
attended lectures on IPA as part of my clinical training, reading relevant books and articles 
about the approach and its methodology, and immersing myself in existing IPA literature. I 
attended all specialist IPA workshops that were offered as an optional extra at university, 
which supported the development of the interview schedule, learning about researcher 
stances, and the analysis process. On two occasions I sought further support from an IPA 
expert to check the credibility of my analysis and interpretation, which led to the 
development of themes and the analytic story. I completed credibility checks in a number of 
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ways, including comparing line-by-line analysis of part of a transcript with a peer, presenting 
an initial and preliminary diagram of emergent themes for participant to a group of peers and 
an IPA expert. I also checked the validity of chosen quotes with a peer, who was able to 
challenge my interpretations and support the development of credible themes. I continually 
sought the expertise of my supervisor to guide me through the process. 
Transparency and coherence 
The methods section of the project clearly outlines the research and analysis process. 
Furthermore, utilising Yardley’s framework has enabled me to show how I have worked to 
ensure quality and validity in the work. I have provided examples of analysis to support an 
audit trail, reflecting how the themes and interpretations have developed and changed over 
time. I have also shared reflexive thoughts highlighting how my personal assumptions and 
experiences interacted with the participant group and influenced the study process. Teaching, 
reading, and supervision ensured the project was in line with IPA’s underlying theoretical 
assumptions at all stages. 
Impact and importance 
The introduction and discussion talks at length about the useful applications of the knowledge 
gained from this research project, in particular noting the clinical implications of the findings. 
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Appendix 12. Self-reflexivity 
From inception to completion of the research project, a reflexive journal was kept to support 
the researcher in creating distance from the immediate context of the research, supporting 
awareness of one’s own assumptions and biases, and how these have impacted the research. 
Considerations of how the institutional context of the project influenced the research process 
were also made. I have chosen to share my reflexive experiences in the context of the 
participants, noting the relationship is one of reciprocity and shared influence. 
Reflexivity and the impact of difference on the study 
I am a 26 year old white British female currently training to be a Clinical Psychologist. I have 
experience working with adults with complex mental health difficulties and who use illicit 
substances as a way to cope and manage. I am experienced in using formulation to make 
sense of an individual’s difficulties, and I am aware of the importance of considering a 
multitude of biopsychosocial factors. I have personal experience of family members 
struggling with drug addiction and have noticed the impact of drug use on their cognitive 
functioning. I am also aware of the stigma related to drug use in society, perceiving it as a life 
choice rather than an outcome of extremely adverse circumstance. These experiences 
influenced the assumptions I had before I began the study, such that a drug-using population 
experience a wide-range of difficulties, often associated with mental health, and adequate 
support is not widely available. Prior to this study, I had not been in contact with chronic 
illicit opiate-users. I noticed my trepidation in starting the research project, and particularly 
felt anxious about my role as a researcher, compared to my more primary professional 
identity (with which I feel more comfortable), as a psychologist. 
The power in the researcher-participant relationship was of particular importance, potentially 
impacting what information was shared and what was further explored. The relationship was 
partly informed by my professional status as ‘researcher’, for example aligning with other 
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members of staff in the service, and placing myself in staff offices, rather than communal 
areas for service users. However it was further impacted by other differences between myself 
as a middle-class, highly-educated, and employed individual, and the participants who 
identified as working class, poorly educated, and all unemployed. As a result a powerful 
power-imbalance existed, with myself holding more power than the participants. However, I 
reflected on my own ethnographic position; that of an outsider who wanted to get inside a 
particular group. In this case I perceived that the participants held some level of power over 
the ‘desired’ information, wanted by the researcher and held by the participant. And in fact 
many participants who met the inclusion/exclusion criteria, chose not to take part. I wonder 
whether I was perceived as an intruder, wanting access to personal and private information, 
potentially loaded with feelings of shame and stigma. 
In spite of this, when meeting with participants it was clear that I was both positioned as, and 
behaved in a way that reflected the professional with greater levels of power, organising and 
structuring the meeting, controlling the questions, and choosing to explore, or not explore, 
certain areas. Across the interviews, the disparity between the researcher’s aims and the 
participants’ needs/aims were clear. The researcher was primarily focused on gathering 
information about an individual’s experience of cognitive impairment. However, participants 
often chose to share a fuller and more complete narrative of their life experiences. Although I 
had predicted complexity in the participants, I had assumed that participants would be able to 
compartmentalise their experience of cognitive impairment, for example from their 
experience of addiction. In the earlier interviews I noticed myself struggling to manage the 
interview space. I had emphasised to participants that I would like them to lead the interviews 
as much as me, and to share what was of importance to them. I had not predicted that the 
conversations would deviate so much from the topic of cognitive impairment.  
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I was aware that as the researcher I held the power to close down areas of inquiry, and open 
up others. However, identifying primarily as a trainee clinical psychologist, who embodies 
empathy, recognition, and validation, I felt conflicted over what control I ‘should’ have over 
the interviews. Furthermore, there were expectations from the institutions providing ethical 
approval for the study, that the researcher would behave sympathetically and supportively 
towards participants. I noticed that my ability to actively listen to the sharing of distressing 
experiences, and contain the expression of distressing emotions, may have served to reinforce 
and increase the level of disclosure. Even when directing conversations back to cognitive 
impairment, I noted that the conversation could frequently meander away from this area.  
I reflected on the context of the interviews; in a drug service. This may have provided a 
powerful marker for participants to interpret what the interviews were about, priming them to 
talk more broadly about their experiences of addiction and recovery. For the latter interviews, 
I had better developed my identity as a researcher, and felt better able to balance the need for 
support and validation with the research aims. This experience highlighted the importance of 
reflecting on differences between the researcher and participants, and recognising how they 
might impact the interview process, as we all come with different experiences, contexts, and 
aims.  
These experiences in the interviews consequently impacted the process of analysis and 
reporting. In line with the project objectives, I was required to attempt to separate out 
experiences of cognitive impairment from other experiences, such as drug addiction. This 
was challenging, and at times I felt I was doing the participants a disservice, not reflecting the 
fullness of their experiences. It is therefore important to note that an alternative research 
project could be born out of the existing data, if the focus were to move away from cognitive 
impairment, and toward participants’ life experiences and addiction. Existing research does 
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explore such areas (Larkin & Griffiths, 2002), and therefore was not chosen as the focus of 
the current report. 
When I first came to analyse the data, I was influenced by my assumptions of cognitive 
impairment and the impact it is likely to have on people’s lives. I found myself struggling to 
synthesise and assimilate data that did not fit with this view. In particular, one participant 
differed from the others in the way in which they experienced and made sense of memory and 
thinking difficulties. I was initially concerned about how this contrasting data would impact 
the conclusions of the study, and resultantly the clinical implications. However throughout 
the analysis process I learned how these differences, both from my assumptions and other 
participant experiences, added to the richness of the data. Highlighting such nuances in light 
of contextual information was used to support and elaborate the interpretative process. This 
experience highlighted the importance of following leads that might not fit, and exploring 
things further when it challenges assumptions. 
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Appendix 13. Audit Trail 
 
The following audit trails reflect the stages of analysis, from exploratory comments, to 
emergent themes, to superordinate theme (participant specific), to initial master theme (across 
the group), to the revised master theme for the group. 
 
Table 3.  
Extract from Jack’s interview 
Exploratory comments Interview extract Emergent themes 
Difficulty getting point 
across – trying to 
communicate extent of 
impairment 
 
 
Reliant on wife to take 
medication 
 
 
 
Reliant on wife for 
appointments 
 
 
‘Always’, ‘everything’ 
 
 
 
 
Blocked brain 
P: If I went from 1-10 I said how 
difficulties with me if I gave a 
number, 2 or 3, you know if I 
want to give a number… it makes 
it so hard for me, because always 
even for my medication I don’t 
take it, most often my wife she 
have to remind me, to take my 
medication, even sometimes you 
know, ok you want to take it, 
todays a Thursday, you have to 
get medication from your GP, 
from the pharmacist, tomorrow is 
Tuesday, don’t forget your 
appointment there. Always she 
needs to remember me you know 
everything to, even you know 
when something happen in future, 
I forgot, you know I won’t attend 
my appointment, most the times I 
forgot, she has to remind me. I 
think if I take this medication, my 
brain is blocked 
 
 
 
Big impact on life 
 
Reliance on wife to 
engage/function in life 
 
 
 
 
 
 
 
Complete reliance on wife 
Couldn’t cope alone 
 
Prospective memory 
 
 
Impairment as a result of 
medication  
 
Transformation of the theme over time: 
1. Emergent theme – Reliance on wife, cannot rely on myself 
2. Superordinate theme – Unable to manage condition independently 
3. Initial master theme - Low self-efficacy, lack of agency 
4. Revised master theme – Perceptions of the self as spoiled: perceived changes in 
dependence and independence 
The revision of the master theme was supported by checking the theme in supervision. My 
supervisor challenged the language I used for the initial master theme, as it was informed by 
psychological constructs. They wondered whether it truly reflected what participants had 
said. I therefore went back to the data and ensured the theme title better reflected participants’ 
comments, rather than being influenced by what I wanted to see. 
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Table 4.  
Extract from John’s interview 
Exploratory comments Interview extract Emergent themes 
Working memory – 
holding things in mind 
 
 
 
Do you do anything to 
cope? 
Confusion – due to lack 
of coping strategies or 
misunderstood question? 
 
 
Writing lists to support 
memory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Partner more aware of 
memory difficulties than 
myself 
 
 
 
 
 
 
 
 
 
 
 
Proactive use of 
strategies – writing note, 
reminders for 
appointments, repetition 
I: yeah so holding those sort of 
multiple bits of information in 
your mind is difficult for you 
P: yeah, yeah, really difficult 
I: yeah and in a situation like that 
do you ever do anything to sort of 
i guess try and manage that to try 
and support your memory? 
P: um (pause) not really, i dont 
know what you mean by that 
I: i guess like some people might 
write a list down, do you? 
P: yeah sure yeah. Sometimes i do 
yeh, i do now i do a lot now, i 
never used to 
I: oh ok yeah 
P: cus of obviously um i didnt 
realise how bad my memory was 
getting how bad it was getting you 
know but 
I: and i guess with that sometimes 
certainly with memory sometimes 
its other people that sort of notice 
it before you notice it yourself. 
would did that happen for you, 
were other people sort of saying 
things to you? 
P: my my partner noticed it all the 
time, you've forgotten to do this 
you've forgotten to do that, i've 
asked you to do this you didnt do 
that, and it'd be like oh god, do 
you know what i mean 
I: so she was like one of the first 
sort of people to notice it 
P: yeh  
I: yeah and how i guess how 
thinking about those sorts of 
memory difficulties how is it 
impacting your life, sort of since 
theyve been present?  
P: um it hasnt been too bad, ive 
learnt to er cope and adjust and 
yeh i write notes and um if ive got 
things coming up i have to keep 
like um especially from like 
appointments for here i have texts 
 
 
 
Significant difficulty 
holding information in 
mind  
 
 
 
 
 
 
Memory strategies 
Change – not who he used 
to be 
 
 
Lack of insight into 
memory difficulties 
 
 
 
 
 
 
 
 
 
Burden 
Lack of awareness 
 
 
 
 
 
 
 
 
 
 
 
 
 
Proactive use of memory 
aids – reduces impact of 
difficulties on life 
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Exploratory comments Interview extract Emergent themes 
on my phone il have to keep going 
over the texts like right so thats on 
the 15th, do you know what i 
mean? you know and just sort of 
keep trying to  
I: sort of repetition of that 
information  
P: yeah, yeah, yeah, and just keep 
going on 
 
 
 
 
 
 
 
 
Don’t give up 
 
Transformation of the theme over time: 
1. Emergent theme – Need to be aware of impairment to do anything about it 
2. Superordinate theme – Awareness leads to acceptance leads to coping 
3. Initial master theme – Coping with what I can no longer do – coping strategies 
4. Revised master theme – Coping with a lesser self: acceptance and adaptation 
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Appendix 14. Credibility Checks 
 
Throughout the research project I completed a range of credibility checks to determine 
whether supervisors and peers agreed with my interpretations of the data. These processes 
supported my analysis and resulted in a number of amendments, to ensure the analysis best 
reflected the data, remaining credible and valid. 
 
1. Comparing line by line analysis and emergent themes 
This task was completed early on in the analytic process, when I initially analysed the first 
transcript. Being aware of the potential impact of confirmation bias, I chose to begin with 
line-by-line analysis, reducing the chances of cherry picking data of interest which may have 
been based on my assumptions and hypotheses. A peer also completed line-by-line analysis 
on a section of the transcript (see table 5). In bold I have highlighted areas of disparity 
between my analysis and my peer’s analysis. My peer had interpreted the use of the word 
‘laugh’ as evidence of the participant using humour to cope. Whereas I had interpreted this as 
him describing others laughing at him. For this participant, English was his second language, 
and this disparity highlighted how much of the meaning was shared in the room using facial 
expressions and body language, rather than just relying on words. It also highlighted how I 
had used knowledge from the rest of the transcript to support my interpretation when 
meanings were more ambiguous. My peer also interpreted his comments as stubborn or 
obstinate, whereas I believed the participant was emphasising his lack of control over the 
situation “I don’t want to do something purposely”. Again I was using information from the 
rest of the transcript; for this participant his sense of lack of control was evident throughout. 
This process reflects the importance of the hermeneutic circle, which states “to understand 
any given part, you look to the whole; to understand the whole, you look to the parts” (Smith 
et al., 2009). When I discussed this with my peer, and showed other examples in the 
transcript, we agreed that I had established the most accurate meaning of this data. However 
it indicated how useful it would have been to check my meaning with the participant in the 
moment to ensure I had understood him correctly. 
 
Table 5.  
Line by line analysis by the researcher and a peer using IPA 
Interview extract Line-by-line analysis 
(main researcher) 
Line-by-line 
analysis (peer) 
P: You know the memory difficulties for 
me you know if for example I leave 
something somewhere, I completely, too 
many times I forgot, that things is the 
biggest problems, and like er if I speak 
with someone, or you speak with me 
now, even I speak with somebody, like I 
speak with you, I completely forgot you 
know what did I say, and the 
conversation completely, it stops, and my 
mind goes completely a different way, I 
don’t know what is with my mind, if I 
back again with this conversation, after If 
I come back you know,  if I you know 
….. nothing to me, there are things, I 
Forgetting where 
something is – big 
problem 
 
 
Can’t keep 
conversation going 
 
Can’t remember what 
talking about 
Distracted – by 
internal or external 
stimuli? 
 
Made fun of 
Forgetting where he’s 
left stuff – biggest 
concern 
 
 
Forgetting 
conversations and his 
involvement 
Tangential mind 
 
Confused about own 
mind 
 
Coming back – 
meaning lost 
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Interview extract Line-by-line analysis 
(main researcher) 
Line-by-line 
analysis (peer) 
make something for the fun, or maybe 
they are laughing at me, like for example 
I don’t respect them, they think like this, 
I don’t want to do something purposely, 
but they think like this, or if like or if 
somebody speak with me, or if they 
speak with me my mind is going a 
different way, completely losing 
everything said 
People think 
negatively of me 
Not my fault 
No control 
Mind is distracted, 
can’t control 
mind/thought 
processes 
 
Coping and humour 
Unsure of 
place/identity in 
conversation 
Being stubborn 
/obstinante 
Sometimes has 
control over not 
listening 
Mind not focusing, 
losing new 
information 
 
 
 
2. Summary of a presentation of initial themes for one participant 
During a university qualitative research workshop, I presented the diagram below (figure 1) 
to a group of peers also undertaking IPA, and an IPA expert. I was able to talk through the 
analytic story, explaining how aspects of the participants experience linked together, and 
what particular psychological concepts were triggered in my mind.  
Feedback from the group helped me to think about the initial theme titles, which at this stage 
were much more categorical. I was supported to go back to the participants’ data and use 
their words to develop more appropriate titles that better reflected the data. Feedback also 
supported me in considering how contextual information about Jack could help make sense of 
the data. For example I began to see that how Jack made sense of his impairment (medication 
side effects, trauma), impacted his emotional experience (sadness, loss, anger). Furthermore it 
was interesting to note that Jack’s sense of lack of control over the causes (trauma) were also 
associated with a lack of control over the impairment and its management (not on purpose). 
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Figure 1.  
Initial themes for Jack 
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PART 2: RESEARCH – LITERATURE REVIEW 
 
Cognitive impairment in opiate-dependent populations receiving an opiate-substitution: 
A literature review. 
Abstract 
Introduction: Existing literature suggests chronic opioid use is associated with lasting cognitive 
impairment. However the focus has been on finding a causal mechanism between opiates and 
impairment. Existing reviews have therefore excluded studies and participants on the basis of 
complicating factors such as polydrug use, mental health diagnoses, and brain trauma. 
However, these factors are very common in opiate-using groups, and current reviews may be 
underestimating the level of cognitive impairment in these populations. 
Method: A systematic review of the literature on cognitive impairment in opiate-dependent 
populations receiving opiate substitution was completed. The Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis (PRISMA) guidelines were used.  
Results: This literature review indicated that few studies exist which investigated cognitive 
impairment in typical opiate-dependent populations receiving opiate substitutions. A large 
proportion of available research excluded participants if they reported other drug use, alcohol 
use, mental health diagnoses, head injury, and overdoses. However despite these stringent 
exclusion criteria, studies still reported a significant level of cognitive impairment across a 
broad range of cognitive domains.  
Discussion: Methodological differences and limitations affected the conclusions that could be 
drawn. More research is needed to investigate the level of cognitive impairment in more typical 
opiate-dependent populations who also report concurrent mental health difficulties, polydrug 
use, and experiences of overdose and head injury. 
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1.1 Introduction  
1.1.1 Opiate-use disorder and cognitive impairment 
The aetiology and nature of cognitive impairment is varied (Lezak et al., 2012). Specialist 
services exist to both diagnose and offer support for individuals with cognitive impairment, for 
example memory clinics and rehabilitation services for head injuries. These services recognise 
that an individual with a significant cognitive impairment requires specialised support tailored 
to their needs. One group of individuals who may experience significant cognitive impairment 
are individuals with a substance use disorder. Cognitive deficits have been reported across a 
range of different substances with a range of abuse durations. Animal and human studies have 
revealed neural mechanisms underlying changes in cognition and behaviour as a result of drug 
intoxication. Research indicates that ketamine administration results in a broad range of 
cognitive impairment (Curran & Morgan, 2000), and the negative impact of benzodiazepines 
on memory is well-documented (Curran, 1991). In addition the negative neuropsychological 
effects of cocaine have long been reported, together with the impact of polydrug use (Rosselli 
& Ardila, 1996).  However these changes are transient and cease within hours to days. On the 
other hand, cognitive impairment associated with long-term alcohol use is well-researched and 
widely understood. Damage to the mammillary bodies in the brain results in irreversible 
cognitive impairment, such as amnesia also known as Wernicke-Korsakoff syndrome (Stavro 
et al., 2013; Thomson & Marshall, 2006). Less is understood about the neural mechanisms 
which may underlie the long-term effects of illicit drugs with relation to cognitive functioning. 
However research does indicate that long-lasting effects do exist in a range of illicit drugs 
(Mittenberg & Motta, 1993; Rogers & Robbins, 2001). 
Heroin is a highly addictive illicit substance, and therefore is widely associated with chronic 
and dependent use as compared to recreational use (Gable, 2006). Public Health England (PHE) 
most recently estimated 293,879 opiate-users in England in 2014/15 (PHE, 2015). In 2017, 
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further data gathered reported 146,536 (60%) people with a primary diagnosis of opiate-use 
disorder were in treatment (PHE, 2017). Although laboratory tests with animals indicate that 
pharmaceutical diamorphine (heroin) has no neurotoxic effect (Power et al., 1991), research 
indicates that cognitive impairment could be caused by life-style factors associated with heroin 
use (Darke et al., 2000). Non-fatal overdose can cause anoxia; research suggests there is a poor 
response to overdose in heroin which increases the likelihood of long-lasting brain damage as 
a result of starving the brain of oxygen. Concomitant alcohol abuse is high in illicit drug users 
(with 20% of opiate-dependent users also having an alcohol dependence) and can result in 
alcohol related brain injury (PHE, 2017). Furthermore, traumatic head injury can result from a 
lifestyle of crime, aggression and antisocial behaviour, as people with heroin dependence 
usually develop a tolerance through daily use, which can result in an expensive addiction and 
a motivation to commit crime (Darke et al., 2000; Department of Health, 2017). Consequently 
this population is of importance when considering cognitive impairment associated with 
chronic drug use. 
A large body of research has been dedicated to exploring the extent of cognitive impairment in 
long term opiate-users (Ersche & Sahakian, 2007; Ornstein et al., 2000). Participants have often 
been recruited from drug treatment services as these individuals are a relatively accessible 
group, and represent the largest substance group in treatment (22% more than alcohol services) 
(PHE, 2017). Replacing illicit opiates with another prescribed opiate drug, such as methadone 
or buprenorphine is a common treatment approach for opiate addiction in the UK (Wang et al., 
2013). The use of opiate-substitution therapy is considered to be safe and effective due to their 
different pharmacological characteristics, which make them easier to detoxify from, and are 
associated with fewer complications (Department of Health, 2007). Opiate substitutions are 
more slowly absorbed and have a much longer half-life before elimination. Consequently they 
are associated with reducing mortality and improving quality of life (Connock, et al., 2007). In 
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addition, treatment can provide stability to support lifestyle changes associated with recovery, 
for example employment (Mintzer & Stitzer, 2002). However treatment completion rates are 
currently the lowest of all substance groups at 26% and it is important to consider factors that 
may have an impact on this (PHE, 2017). 
Research to date suggests that long term opiate-use impacts an individual’s cognitive 
functioning, most likely caused by factors associated with illicit drug use, such as concomitant 
alcohol misuse, non-fatal overdose, and traumatic brain injury (Darke et al, 2000). However 
results vary with regard to the aetiology and extent of impairment. In addition, methodological 
differences across studies limit the ability to conclusively determine the impact of opiate-use 
on cognition. For example, studies vary regarding the homogeneity of participant samples and 
may include or exclude on the basis of polydrug use. Furthermore, studies use a range of 
different psychometric tests and different terms to describe the same cognitive function. These 
methodological differences indicate the importance of reviews and meta-analyses to help make 
sense of the available literature. 
In 2012, Baldacchino and colleagues completed a meta-analysis to establish the extent of 
cognitive impairment in chronic opiate-users (Baldacchino et al., 2012). Their findings 
suggested that significant and reliable impairment was found in three cognitive domains; verbal 
working memory, cognitive impulsivity, and cognitive flexibility. A more recent meta-analysis 
by Baldacchino and colleagues (published during the completion of this literature review) 
further investigated cognitive impairment in chronic methadone users (Baldacchino et al., 
2017). Conclusions reported significant and reliable global cognitive impairment in many 
cognitive domains, including cognitive impulsivity and flexibility, attention, short term 
memory, and long term memory. These results expand on the three impaired cognitive domains 
reported in the 2012 meta-analysis, suggesting a significant level of impairment in people in 
treatment. However these meta-analyses focused on establishing the causal role of opiate-use 
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alone on cognitive functioning. As a result they excluded a number of studies on the basis of 
the complexity of participants, to minimise possible confounding variables. For example 
studies were excluded if they investigated cognition in people with past or present alcohol 
use/dependence and polydrug use. The authors recognised this as a limitation in their paper, 
commenting on the difficulties controlling for complex drug-taking histories that are typical in 
opiate-dependent populations. 
Many of the existing literature reviews seek to determine whether chronic opiate-use alone can 
cause lasting cognitive impairment. These studies have developed our understanding of the 
damaging impact of chronic opiate-use on cognitive functioning. However it is important to 
consider the heterogeneity of an opiate-dependent population. Figures from Public Health 
England in 2017 estimated that a significant proportion of opiate-users in treatment also present 
with other drug dependencies, including 42% with crack cocaine, 20% with alcohol, 18% with 
cannabis, and 11% with benzodiazepines (PHE, 2017). Excluding these individuals from 
research and reviews may result in an underestimation of impairment reported in people with 
an opiate-use disorder. In fact, cognitive impairment in opiate-users is likely to be multi-
factorial, with research suggesting that high rates of alcohol dependence, head injury, and 
heroin overdose best explain cognitive impairment (Darke et al., 2000). These factors identify 
the need for a review of the literature which investigates cognitive impairment in a typical 
sample of chronic opiate-users in treatment, including individuals with polydrug use, alcohol 
misuse, and mental health disorders. 
1.1.2 The impact of cognitive impairment on treatment 
Recognising the extent of cognitive impairment in a typical opiate-dependent population 
attending a drug and alcohol service could identify a need for such deficits to be considered in 
the treatment programmes. Cognitive impairment may impact an individual’s ability to engage 
and benefit from treatment. For example, deficits in verbal working memory may make it 
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difficult to understand instructions and impair the ability to learn and remember information; 
consequences may include missed appointments. Executive dysfunction, such as cognitive 
impulsivity may result in poor problem solving and risk taking behaviours. Research has 
highlighted that substance dependent individuals have difficulties anticipating and considering 
negative long term consequences (Barry & Petry, 2008) including hazardous risk taking 
(Passetti, 2011). These are integral processes that facilitate recovery. Structured and concrete 
management approaches may be appropriate for helping individuals with the above difficulties 
(Baldacchino et al., 2012). Help with the management of cognitive impairments could improve 
the chances of recovery across a number of areas including problem solving, learning strategies 
for relapse prevention, and managing impulsive decision taking, to name but a few.  
Chronic drug use is associated with low employment rates (French et al., 2001), and substance 
dependent individuals report a poorer quality of life when compared to the general population 
(De Maeyer et al., 2010). There is a need for effective treatment approaches that take into 
consideration the potential impact of cognitive impairment. Recently there has been 
recognition that cognitive impairment in schizophrenia is a reliable and distinct aspect of the 
illness which predicts functional outcomes and disability (Gold, 2004; Harvey & Strassnig, 
2012). Consequently these deficits limit the effectiveness of psychological treatments for 
schizophrenia (Green et al., 2000) and it is possible this may also be the case with substance 
misusers. 
1.2 Objectives 
This literature review aimed to identify, review, critically appraise and synthesise empirical 
evidence which explores the extent of cognitive impairment in a typically heterogeneous 
population of opiate-dependent individuals receiving opiate-substitution. The review included 
studies that have investigated cognitive impairment in a chronic opiate-dependent population 
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who were attending a service for opiate-substitution treatment (methadone, buprenorphine). 
Studies were included if participants had other drug dependencies, i.e. alcohol, 
benzodiazepines, and other illicit drugs. Studies were also included if participants had 
diagnosed mental health difficulties. Studies that excluded participants due to the above factors 
were also included in the literature review, as these formed a large part of the available 
literature. Studies were included when a population of opioid naïve healthy controls were used 
as a comparison group.  
The question guiding the review was; are there studies which explore the presence and extent 
of cognitive impairment in a typical heterogeneous population of chronic opiate-users attending 
an opiate-substitution service, which were not included in Baldacchino’s current meta-analyses 
which employed strict inclusion criteria and highly controlled participants (2012; 2017)? It is 
anticipated that such studies do exist, and they may provide evidence of the true extent of 
cognitive impairment in the more typical, heterogeneous population of opiate-users in 
treatment.  
2.1 Method 
2.1.1 Search strategy 
Primarily an electronic search strategy was used. Psych Cross Search (1806-March 2017) was 
used to access PsycINFO, PsycARTICLES, PsycBOOKs, Medline and the Psychology & 
Behavioral Sciences Collection, enabling a search of over 500 journals. Web of Science (1900-
March 2017), provided by the Web of Knowledge Service for UK Education was also used to 
identify studies. In addition a hand based search strategy was used to locate any important 
articles that had not been identified in the search, but had been found in relevant systematic 
reviews and meta-analyses carried out in the field of cognitive impairment in opiate-users. 
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The search terms included a combination of thesaurus terms for the categories of ‘cognitive’, 
‘function’, and ‘opiate’, and a Boolean search strategy was used. The first search string was as 
follows; TI ( cogniti* OR neurobehavioural OR neuropsychological ) AND TI ( deficit* OR 
abilit* OR effect* OR function* OR dysfunction* OR impairment* ) AND TI ( opiate* OR 
methadone OR buprenorphine OR opioid* OR heroin ). The second and third search terms 
replaced ‘cognitive’ with different terms for a range of cognitive domains, as follows; TI ( 
opiate* OR methadone OR buprenorphine OR opioid* OR heroin ) AND TI ( working memory 
OR episodic memory OR visuospatial OR executive function* OR verbal fluency OR digit 
symbol substitution OR intelligence OR reaction time OR attention OR short term memory OR 
long term memory ), and, TI ( opiate* OR methadone OR buprenorphine OR opioid* OR heroin 
) AND TI ( decision making OR decision-making OR impulsiv* OR flexibility ). All three search 
strings were entered separately into both Psych Cross Search and Web of Science, and titles 
only were searched, with no language restrictions being applied. 
2.1.2 Study Selection 
The first stage was to screen all articles for their relevance to the current literature review, 
based on their title with further information gathered from the abstract if necessary. Studies 
were excluded at this stage if they were deemed ‘not relevant to search’. This often included 
studies investigating the effects of opiates in chronic pain settings, or the impact of opiates in 
utero. In addition animal studies and theoretical reviews were excluded at this stage. Studies 
were then assessed in further detail through examining the abstracts and methodologies, and 
chosen based on the following inclusion and exclusion criteria. 
2.1.2 Inclusion and exclusion criteria 
Experimental studies including randomised controlled trials and cross-sectional designs were 
included. Longitudinal studies were included only if data from one chosen time-point was 
analysed. Quantitative studies which only used self-report measures of cognitive functioning 
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were not included as these measures do not have comparable reliability and validity to 
psychometric measures. Therefore it would have been challenging to compare and contrast 
results from studies using only self-report measures and studies using only psychometric 
measures; and this is not the primary focus of this literature review.  
Research papers were required to meet the following criteria to be included in this review; 
1) participants must be aged 18 or over  
2) drug group must meet DSM-V (American Psychiatric Association, 2013) criteria for a 
diagnosis of opiate-use disorder and have had the diagnosis for over 6 months 
3) drug group must be attending a substance misuse service receiving an opiate-
substitution, such as methadone or buprenorphine 
4) drug group must not be acutely intoxicated or in withdrawal at time of testing  
5) comparison group must be an opioid naive healthy2 participant group 
6) psychometric tests were used, i.e. not self-report measures 
7) published after 1985 
This literature review employed less stringent exclusion criteria based on the characteristics of 
the drug groups, which is in contrast to existing reviews discussed earlier. Therefore studies 
were included if participants in the drug group were polydrug users of licit or illicit drugs, 
including other opiates, benzodiazepines, amphetamines, cannabis, alcohol, and tobacco. 
Studies were also included if participants in the drug group had co-morbid mental health 
diagnoses, and a history of head injury, as these are common experiences in a drug-using 
population (Darke et al., 2000; Harvard et al., 2006). Studies were further excluded based on 
the quality of the paper and these factors are discussed below.  
                                                     
2 Healthy refers to participants who had no current or past diagnosis of any alcohol or drug use disorder, no 
psychotic disorders, and no neurological conditions. 
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2.1.3 Study review 
A number of the studies included multiple participant groups which included opiate-
substitution users, abstinent users, and healthy controls. In these instances only the relevant 
group comparisons were examined; opiate-substitution group vs. healthy control group. In 
some cases, groups were defined based on the type of opiate substitution used. Only group 
comparisons between each opiate substitution group and the healthy control group were 
examined. Data were examined and included separately if within the same study comparisons 
were made between buprenorphine vs. control and methadone vs. control. Therefore 
comparisons between the opiate-substitution group and abstinent groups, or, a methadone 
group and a buprenorphine group were disregarded. In all cases the comparison group was the 
healthy control group. As a result, only studies that reported the necessary post-hoc statistics 
of these group analyses (healthy control vs. opiate substitution group only) were included. 
Studies that only reported overall F-statistics indicating group differences between i.e. healthy 
control group and all drug groups (opiate-substitution users and abstinent users) had to be 
excluded. Therefore in some cases studies were excluded on the basis of there not being enough 
detail in the analysis to meet the current literature review’s aims. 
 2.1.4 Cognitive Domains 
Throughout the literature cognitive domains are often given varying labels, for example, 
problem solving vs non-planning impulsivity; inhibition vs motor impulsivity. In addition there 
are a large number of psychometric tests that can be used to assess functioning in a particular 
domain, for example cognitive flexibility can be assessed using the Wisconsin Card Sorting 
Task (WCST), or the Trails Making Test (TMT), or a measure of verbal fluency such as the 
Controlled Oral Word Association Test (COWAT). Previous meta-analyses published by 
Baldacchino and colleagues (2012; 2017) employed a system in which all psychometric tests 
were coded into one of seven cognitive domains (Ersche & Sahakian, 2007). To ensure this 
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literature review could be compared to existing reviews, this current review used the same 
coding system. Table 1 indicates the seven cognitive domains, alternative names for these 
domains, and their associated psychometric tests that appear in this literature review. This 
coding system is informed by existing factor analyses (Goldstein, 2004; Passolunghi & 
Mammarella, 2010) and ensured an objective and consistent approach was maintained across 
the literature when evaluating cognitive functioning. 
Table 1 
The seven cognitive domains and their associated neuropsychological tests 
Cognitive 
Domain 
Alternative Names Definition Psychometric Tests 
Attention and 
Information 
Processing 
Arousal/Alertness 
Attentional 
Capacity 
 
 
 
Focused Attention/ 
Selective Attention 
 
Sustained Attention 
Ability for individuals to 
hold information in mind 
and process, or process 
tasks simultaneously 
 
 
Ability to reject 
irrelevant information 
while attending to 
relevant input 
Readiness to detect 
rarely and unpredictable 
occurring signals over 
long periods of time 
DSST 
DSST, WAIS Digit 
Symbol, WAIS 
Symbol Search, 
WAIS Digit Span, 
MTT, SDMT 
 
CT-I, ST, ACT, CRT, 
SS, RSA, SSST 
PASAT, ACPT, CPT, 
ACT,  
Short Term 
Memory 
Verbal Working 
Memory 
 
Visuospatial (non 
verbal) Working 
Memory 
Reproduction, 
recognition or recall of 
information directly or 
sometime after 
presentation 
RAVLT, CVLT, 
WAIS Digit Span, 
WMS LNS, 2BT, 
HVLT-R 
PAL, BVRT, WMS, 
ROCFT,  CCDT, 3D-
BCM, WAIS Block 
Design, Object 
Assembly, BVMT-R 
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Cognitive 
Domain 
Alternative Names Definition Psychometric Tests 
Longer Term 
Memory 
Autobiographical, 
episodic, event 
 
Semantic 
 
 
Prospective 
Memory 
Records details salient to 
individual’s life 
 
“Knowing that”, 
meanings of words and 
concepts, or facts 
The ability to perform 
intended actions in the 
future 
SOMT, WSLT, 
BVRT, CVLT, 
RAVLT, ROCFT, 
WMS-R 
ROCFT, RRLET, 
SAVF, WMS-R 
 
Virtual Week 
Cognitive 
Impulsivity 
Delay Discounting/ 
Risk Taking 
 
Cognitive 
Inhibition 
Ability to opt for larger 
delayed rewards over 
smaller more immediate 
rewards 
Process required to 
suppress a salient but 
conflicting stimulus 
while identifying a less 
salient one 
IGT, CGT, GT, DDT 
 
 
ST 
Motor 
Impulsivity 
Inhibitory Control Ability to suppress 
emotional, cognitive, and 
behavioural responses 
Go/NoGo, SS, ST 
Non-Planning 
Impulsivity 
Problem Solving 
Reasoning 
Strategic Planning 
Ability to think ahead 
and actively search for 
an appropriate solution 
SOC, ROCFT, 
PMQS, MT, Matrix 
Reasoning, BADS 
Cognitive 
Flexibility 
Perseveration 
 
Verbal Fluency 
Ability to realign a 
behavioural disposition 
to altered contingencies 
Requires the intrinsic 
generation of responses 
or alternatives 
WCST, TMT-B, CT 
II 
 
COWAT, FAS, BNT, 
HSC, CLFT 
2BT=Two Back Task; 3D-BCM=Three Dimensional Block Construction Model; ACPT=Auditory Continuous 
Performance Task; ACT=Attentional Capture Task; BADS=Behavioural Assessment of Dysexecutive Syndrome; 
BNT=Boston Naming Test; BVMT-R=Brief Visual Memory Test-Revised; BVRT=Benton Visual Retention 
Test; CCDT=Colour Change Detection Task; CGT=Cambridge Gambling Task; CLFT=Category and Letter 
Fluency Task; COWAT=Controlled Oral Association Word Test; CPT=Continuous Performance Task; CT 
I&II=Colour Trails Test; CRT=Choice Reaction Time; CVLT=California Verbal Learning Test; DDT=Delay 
Discounting Task; DSST=Digit Symbol Substitution Test; FAS=Phonological Fluency Test; GT=Gambling Task; 
HSC=Hayling Sentence Completion; HVLT-R=Hopkins Verbal Learning Test-Revised; IGT=Iowa Gambling 
Task; LNS=Letter Number Sequencing; MT=Maze Test; MTT=Motor Tapping Test PAL=Paired Associate 
Learning; PASAT=Paced Auditory Serial Addition Task; PM=Porteus Maze Test; RAVLT=Rey Auditory Verbal 
Learning Test; ROCFT=Rey Osterreith Complex Figures Test; RRLET=Remote and Recent Life Event Test; 
RSA=Ruff 2&7 Selective Attention Test; SAVF=Semantic Association of Verbal Fluency; SDMT=Symbol 
Digits Modalities Test; SOC=Stockings of Cambridge; SOMT=Six Object Memory Test; SS=Stop Signal; 
SSST=Serial Seven Subtraction Task; ST=Stroop Test; TAP=Test for Attentional Performance; TMT 
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A&B=Trails Making Test; WAIS=Weschler Adult Intelligence Scale; WCST=Wisconsin Card Sorting Test; 
WMS=Weschler Memory Scale; WSLT=Word Sequence Learning Test.     
 
2.1.5 Assessment of study quality 
The quality of all articles included in the final literature review were assessed using guidance 
from the Effective Public Health Practice Project (EPHPP) quality assessment checklist 
(Armijo-Olivo et al., 2012), a tool used in existing systematic reviews in the field of substance 
misuse and cognitive impairment. The following criteria were considered: 
1) Selection of study participants and a clear explanation of inclusion/exclusion criteria 
2) Psychometric tests are clearly described and have fair reliability and validity 
3) Confounding variables – consideration for what other factors may contribute to the 
study results and the extent to which these were controlled for 
4) Statistical analysis clearly describes all primary outcomes, as stated in the aims, and 
provide adequate detail 
5) The extent to which the study’s conclusions reflect the results 
It is important to consider that there is a considerable publication bias in the literature, meaning 
that studies which find significant results are more likely to be published than studies that do 
not (Fanelli, 2012). It is therefore likely that studies which found no significant differences in 
cognitive functioning between opiate-substitution users and healthy controls are 
underrepresented in this literature review. 
3.1 Results 
3.1.1 Study Selection 
Figure 1 uses a flow diagram developed by the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) to illustrate the number of articles that were identified, 
screened, and included in the literature review (Moher et al. 2009). A total of 677 records were 
identified using electronic and hand searching. After duplicates were removed 439 were 
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initially screened to determine their relevance to the literature review. At this stage 292 were 
considered not relevant to the search, 31 were animal studies, and 6 were theoretical reviews. 
Following this 110 were assessed for eligibility based on inclusion and exclusion criteria. 
Studies were excluded if they only investigated acute/toxic effects of opiates (n=2), where the 
drug group were abstinent users or not taking an opiate substitution (n=16), where there was 
no appropriate healthy control group (n=15), where no psychometric tests were used (n=11), if 
the full articles were not accessible3 (n=30), and if the paper was published before 1985 (n=5). 
Following this, 31 articles were fully examined for eligibility, and further studies were 
excluded based on the quality of the study. Six studies were excluded due to lack of detail in 
the publication, for example information was missing with regard to inclusion/exclusion 
criteria, information about participants, procedure, and necessary group comparisons and 
statistics. This lack of information made it challenging to assess the quality of the study and/or 
evaluate group differences. A further five studies were excluded based on their choice of 
psychometric tests; for example three studies only included tests focused on ‘driving aptitude’ 
such as visual orientation and reaction times (functions which were not tested in remaining 
studies). One article was excluded based on the low quality of the journal, decided on the basis 
of incorrect and non-existent DOI links, and all studies in the journal coming from one 
university only. 
Figure 1 
A flow diagram to illustrate the number of articles that were identified, screened, and included 
in the literature review taken from the PRISMA 2009 guidelines (Moher et al., 2009). 
 
 
 
                                                     
3 Full articles were often not available in cases where a published abstract had not been followed up with a 
published study. Furthermore abstracts were often discovered in the form of a conference presentation only. 
Finally, if full articles were not accessible via the internet, researchers were contacted via email to request the 
full article. 
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3.1.2 Study Characteristics 
A total of 19 research studies were included in this literature review, 18 of which were non-
randomised cross-sectional studies. One longitudinal study was included (Rapeli et al., 2011), 
and results from T1 only were reported in this review. No qualitative studies investigating 
cognitive functioning in opiate-users were found in the search process. The majority of studies 
tested participants taking methadone only (n=14). In addition, one study investigated 
participants taking buprenorphine only (Messinis et al., 2009), and two studies tested 
participants on varying opiate-substitutions but categorised them into the same “drug group” 
(McDonald et al., 2012; Terrett et al., 2014). Two studies compared cognitive functioning 
between a methadone group, a buprenorphine group, and a control group (Pirastu et al., 2006; 
Rapeli et al., 2011). 
The final 19 studies tested a total of 915 individuals who at the time of testing were receiving 
an opiate-substitution for an opiate-use disorder (see table 1 for full study details). Across these 
915 participants, 77.3% were male, with an average age of 36.0 years, undertaking an average 
of 10.8 years in education (one study did not report years in education, Tolomeo et al., 2016), 
with an average estimated pre-morbid Full Scale IQ of 97.8 (reported in nine studies; four 
further studies measured pre-morbid IQ but did not report a Full Scale IQ score). On average 
participants in the opiate-substitution groups had used opiates for 12.4 years. 828 participants 
were taking methadone, with an average daily dose of 66.6mg, however three studies did not 
report the daily dose (Gupta et al., 2014; Mehrjerdi et al., 2011; Zeng et al., 2016). There were 
a total of 84 participants taking buprenorphine with an average daily dose of 10.1mg. One study 
included three individuals taking suboxone in combination with buprenorphine, with an 
average daily dose of 8mg (Terrett et al., 2014). Overall, 839 healthy control participants were 
tested. Across these participants, 70.7% were male, with an average age of 32.5 years, and 
undertaking an average of 12.1 years in education. Of the nine studies which used measures to 
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gather a standardised score of IQ (where 100=average), the control participants had an average 
IQ of 104.8, compared to an average IQ of 97.8 in the healthy control participants.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
99 
 
Table 1 
Characteristics of studies included in the literature review (n=19) 
Study  
 
 
Journal 
article 
impact H-
index 
Opiate-
substitutio
n group 
 
 
 
N 
 
 
 
 
Age 
Year
s 
 
 
 
Gende
r 
% 
Male 
 
 
 
Mean 
years in 
educatio
n 
 
 
 
 
Mean 
estimate
d IQ 
 
 
Mean/Mi
n 
years of 
opiate-
use 
 
 
 
 
Substituti
on 
 
 
 
Mean 
years of 
substitutio
n 
 
 
Mean 
daily dose 
of 
substitutio
n mg 
Control 
Group 
 
 
 
 
N 
 
 
 
Age 
Years 
 
 
 
Gende
r 
% 
Male 
 
 
 
Mean 
years in 
educatio
n 
 
 
Mea
n 
estim
ated 
IQ 
Darke et 
al., 2000 
158 30 35.8 60 11.2 91.5 n/a Methadone Median 5 
years 
78.6 30 35.2 60 11.7 92.6 
Mintzer & 
Stitzer, 
2002 
 
135 18 37.6 39.0 11.8 87.4 n/a Methadone 3.8 67.2 21 34.9 48.0 12.2 94.0 
Pirastu et 
al., 2006 
135 48 34.0 96.6 8.5 87.2 14.4 Methadone 
(30) or 
Buprenorp
hine (18) 
6.85 Meth: 66 
Bup: 9 
21 34.0 66.6 10.9 104.0 
Prosser et 
al., 2006 
135 29 37.9 79.3 13.0 8.14 15.1 Methadone 6.4 73.8 29 34.0 72.4 15.5 12.24 
Prosser et 
al., 2009 
135 10 40.6 90.0 11.9 8.24 19.0 Methadone 4.7 76.0 14 33.0 71.4 15.5 12.44 
Messinis et 
al., 2009 
66 18 36.5 83.3 11.0 94.3 12.8 Buprenorp
hine 
0.4-0.5 6.8 34 35.7 79.4 11.5 97.9 
Fadardi & 
Ziaee, 
2010 
77 53 36.6 100 10.3 n/a Min 4 Methadone 2.0 75 71 26.6 54 14.2 n/a 
Mehrjerdi 
et al., 2011 
7 60 20.3 100 11.4 n/a 4.0 Methadone 17 days n/a 60 20.2 100 12.3 n/a 
Rapeli et 
al., 2011 
32 26 30.5 57 10.0 99.5 n/a Methadone 
(12)  or 
Buprenorp
hine (14) 
 
20.5 days Meth: 71 
Bup: 16 
14 29.0 50 13 105 
                                                     
4 WAIS-III Vocabulary subtest 
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Study  
 
 
Journal 
article 
impact H-
index 
Opiate-
substitutio
n group 
 
 
 
N 
 
 
 
 
Age 
Year
s 
 
 
 
Gende
r 
% 
Male 
 
 
 
Mean 
years in 
educatio
n 
 
 
 
 
Mean 
estimate
d IQ 
 
 
Mean/Mi
n 
years of 
opiate-
use 
 
 
 
 
Substituti
on 
 
 
 
Mean 
years of 
substitutio
n 
 
 
Mean 
daily dose 
of 
substitutio
n mg 
Control 
Group 
 
 
 
 
N 
 
 
 
Age 
Years 
 
 
 
Gende
r 
% 
Male 
 
 
 
Mean 
years in 
educatio
n 
 
 
Mea
n 
estim
ated 
IQ 
Lin et al., 
2012 
93 27 36.8 96 10.3 n/a 13.9 Methadone 1.7 36 23 34.0 96 15.4 n/a 
McDonald 
et al., 2012 
158 125 38.2 64 9.8 98.3 19.4 Methadone 
(94) or 
Buprenorp
hine(31) 
6.1 Meth: 82.7 
Bup: 10.6 
50 35.8 68 11.2 105 
Anderson 
et al., 2013 
77 17 44.4 53 11.5 n/a Min 1.7 Methadone Min 0.5 77.9 17 42.9 53 14.7  n/a 
Wang et 
al., 2014 
92 32 39.4 56 12.1 45.75 10.0 Methadone 7.3 70.9 25 36.1 56 13.7 44.35 
Terrett et 
al., 2014 
171 26 38.3 69 12.9 110.4 19.0 Methadone 
(20) 
Buprenorp
hine (3) 
Suboxone 
(3) 
n/a Meth: 56.3 
Bup: 8 
Sub: 8 
30 39.5 53 13.8 108.9 
Gupta et 
al., 2014 
135 195 35.8 65.1 9.8 n/a 14.0 Methadone 0.7 n/a 198 34.6 66.2 9.9 n/a 
Liao et al., 
2014 
218 65 40.2 100 8.6 n/a 14.3 Methadone 0.5 45 64 36.8 100 9.3 n/a 
Baldacchin
o et al., 
2015 
170 29 29 100 10.6 108.9 8.8 Methadone 0.5 55.8 28 24.1 100 15.4 118.3 
Tolomeo et 
al, 2016 
170 48 30.2 100 n/a 103.0 9.2 Methadone Min 6m 66.6 50 28 100 n/a 117.9 
Zeng et al., 
2016 
108 59 42.3 61 9.3 35.76 12.1 Methadone 3.5 4.6 60 23.3 50 10.5 37.26 
                                                     
5 Spot the real word – accuracy (IntegNeuro, Brain Resource Company, Australia) 
6 Raven’s Progressive Matrices subtest 
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3.1.3 Study inclusion/exclusion criteria 
Existing systematic reviews of the literature define stringent inclusion and exclusion criteria to 
ensure the sample of participants are homogeneous, therefore aiding their ability to make 
conclusions about the effects of opiates alone on cognitive functioning (Baldacchino et al., 
2012; 2017). However, people in treatment services for opiate-use disorders represent a 
heterogeneous group, and commonly have a range of other licit and illicit drug dependencies, 
and additional mental health diagnoses (PHE, 2017). Therefore a primary aim of this literature 
review was to consider studies that have included participants with poly drug use and mental 
health diagnoses. Of the 19 studies included in this literature review, 12 were also included in 
at least one of Baldacchino’s reviews (2012; 2017). Therefore only a further seven studies were 
included which had not been considered in Baldacchino’s reviews, highlighting the paucity of 
research including a typical and heterogeneous sample of opiate-users. 
Within the available literature, the majority of studies applied stringent inclusion/exclusion 
criteria (see table 2 for full details). Only seven studies clearly stated that they allowed 
participants to take part if they also had other drug dependencies or concurrently used other 
drugs (Darke et al., 2000; Liao et al., 2014; Mintzer & Stitzer, 2002; Rapeli et al., 2011; Terrett 
et al., 2014; Wang et al., 2014; Zeng et al., 2016). One of these studies however only included 
people using benzodiazepines and cannabis, and excluded participants on the basis of any other 
drug use (Rapeli et al., 2011). Only two studies included participants who also reported current 
heavy alcohol use or an alcohol dependency (Darke et al., 2000; Zeng et al., 2016). Excluding 
such individuals’ from the research reduces the generalisability of the literature, as the 
participants do not represent a typical opiate-using population.  
All studies only included participants in the drug group if they had a diagnosed opiate-use 
disorder. However concurrent mental health diagnoses were also considered as an important 
eligibility criteria in many studies. Of the 19 studies, nine excluded anybody with an Axis I 
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diagnosis, which included depression and anxiety. A further seven studies excluded 
participants if they had what was named as a ‘major psychiatric disorder’, such as psychosis or 
post-traumatic stress disorder. Seven studies also excluded people if they had a personality 
disorder diagnosis (including personality disorder as a major psychopathology/psychiatric 
condition). Consequently, it is possible that eight studies included people with a mental health 
diagnosis such as depression or anxiety (Baldacchino et al., 2015; Darke et al., 2000; Gupta et 
al., 2014; Liao et al., 2014; Mehrjerdi et al., 2011; Messinis et al., 2009; Tolomeo et al., 2016; 
Zeng et al., 2016), although this was not explicitly stated in all the methodologies. However it 
is important to note that although these studies, in theory, allowed such people to take part, it 
does not necessarily mean that people with mental health diagnoses formed part of the final 
participant group.  
Other factors that have been commonly reported in people in treatment for an opiate-use 
disorder are head injuries and drug overdoses. Of the 15 studies that explicitly reported head 
injury as an eligibility criteria, only two studies included such participants (Darke et al., 2000; 
McDonald et al., 2012). History of overdose was less commonly stated as an eligibility criteria, 
however two of the four studies that did report it excluded participants with a history of 
overdose (Baldacchino et al., 2015; Tolomeo et al., 2016), and two included them (Darke et 
al., 2000; McDonald et al., 2012). It was unclear whether the remaining 15 studies included 
participants with a history of drug overdose, however it could be assumed that studies that did 
not report it, did not assess for it, and therefore may have included participants, whether 
knowingly or not, with a history of overdose. All studies excluded participants if they had any 
neurological disorders.  
Table 2 
Inclusion and exclusion criteria as reported in the 19 studies for the opiate-dependent groups. 
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Studies Inclusion Criteria Exclusion Criteria 
Darke et al., 
2000 
History of overdose; Head injury; Alcohol 
dependence; Other drug use; Mental 
health diagnoses 
Not stated 
Mintzer & 
Stitzer, 2002 
Other drug use 
 
Axis I disorder; Recent Benzodiazepine use; 
Current Alcohol dependence 
Pirastu et al., 
2006 
Not stated 
 
Axis I disorder; Head trauma; Other past/ 
present drug/ alcohol dependencies 
Prosser et al., 
2006 
Not stated 
 
Current other illicit drug use; 
Current/historical Axis I&II; Head trauma; 
Alcohol >15 drinks/week 
Prosser et al., 
2009 
Not stated 
 
Other illicit drug use (past 18m); 
Current/historical Axis I disorder; Head 
trauma; Current alcohol use 
Messinis et al., 
2009 
Not stated 
 
Current other illicit drug use; Major 
psychopathology; Head trauma; 
Alcohol/drug dependencies 6 months pre 
treatment 
Fadardi & 
Ziaee, 2010 
Not stated 
 
Not stated 
Mehrjerdi et 
al., 2011 
Not stated 
 
History of drug injection; Polydrug use in 
past 12m; Current/historical psychiatric 
condition affecting cognition 
Rapeli et al., 
2011 
Benzodiazepine dependency; Recent 
alcohol/ cannabis abuse 
 
Uncontrolled polysubstance abuse; Acute 
alcohol abuse; Acute Axis I 
Lin et al., 2012 12 months illict drug free; Heroin-induced 
depression 
 
 
Current/historical Axis I disorder; Head 
trauma; Alcohol>15 drinks/week; Current 
Benzodiazepine use; Current/historical other 
dependencies 
McDonald et 
al., 2012 
Head injuries; Historical drinking; 
Overdoses 
Not stated 
Anderson et al., 
2013 
Not stated Past 3m other illicit drug use; Axis I 
diagnosis; Alcohol dependence 
Wang et al., 
2014 
Other illicit drug use  
 
Axis I & II diagnosis; Head trauma 
Terrett et al., 
2014 
Other illicit drug use; Alcohol use 
 
Heavy alcohol use; Psychiatric disorder; 
Acquired Brain Injury 
Gupta et al., 
2014 
Hepatitis C 
 
Psychosis; Head injury; Current substance 
use disorders 
Liao et al., 
2014 
Other Axis I or II diagnosis; Other 
substance use 
Current/historical psychotic disorder; Head 
injury 
Baldacchino et 
al., 2015 
Not stated Current/historical psychosis, PTSD, 
Personality Disorder; Head injuries; 
Overdoses; Other substance dependencies; 6 
month previous illicit drug use 
Tolomeo et al, 
2016 
Not stated Current/historical psychosis, PTSD, 
Personality Disorder’ Head injury; 
Overdose; Current other drug/alcohol 
dependencies; 6 month illicit drug use 
Zeng et al., 
2016 
Other dependencies; 24 hour abstinence Current/historical major psychiatric disorder 
Serious head injury 
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3.2 Study findings 
A range of psychometric tests were used to assess a range of different cognitive domains (see 
table 3). As described in the method, these were categorised according to existing literature 
and factor analyses.  
Table 3 
Psychometric tests used for each study (n=19) 
Study Cognitive domain  Psychometric Test 
Darke et al., 
2000 
Processing Speed 
Attention  
Visual Memory  
Verbal Memory  
Problem Solving  
 
WAIS-II Digit Symbol and Symbol Search WAIS-II 
Digit Span  
WMS-R VR I &II; ROCFT 
WMS-R PAL I & II; CVLT 
COWAT; WCST 
Mintzer & 
Stitzer, 
2002 
 
Processing Speed 
Selective Attention 
Time Perception 
Working Memory  
Long Term Verbal Memory  
Cognitive Flexibility  
Decision Making  
 
DSST 
ST 
Time estimation 
2BT 
Recognition memory and free recall 
TMT 
GT 
Pirastu et 
al., 2006 
Visual Perception & Memory  
Cognitive Flexibility  
Decision Making  
 
BVRT 
WCST 
IGT 
Prosser et 
al., 2006 
Sustained Attention  
Verbal Fluency  
Visual Perception & Memory  
 
ST 
COWAT 
BVRT 
Prosser et 
al., 2009 
Sustained Attention  
 
 
Auditory Continuous Performance Task 
Messinis et 
al., 2009 
Processing Speed  
Selective-sustained Attention 
Visual Memory  
Verbal Fluency 
Executive Functioning  
 
SDMT; CTT-I 
RSA 
RAVLT; CFT 
BNT 
CTT-II 
Fadardi & 
Ziaee, 2010 
Attentional Bias  
 
 
ST 
Mehrjerdi et 
al., 2011 
Attention  
Complex attention  
Cognitive Flexibility  
Impulsivity  
 
Serial seven subtraction test 
CTT 
WCST 
PMQS 
Rapeli et 
al., 2011 
Attention: simple and selective  
Working Memory  
Verbal Memory  
 
Go/NoGo 
WMS-III LNS; PASAT 
WMS-III LM I&II 
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Study Cognitive domain  Psychometric Test 
Lin et al., 
2012 
Visual construction  
Episodic Memory  
Semantic Memory  
Executive Functions  
3D-BCM; BD; OA  
SOMT; WSLT; BVRT 
RRLET; SAVF 
WAIS-R – DFS, DBS; Digit Symbol; Similarities; 
Arithmetic; Proverbs 
McDonald 
et al., 2012 
Processing Speed  
Working Memory  
Verbal Memory 
Visual Memory  
Executive Functions  
 
Social Perception  
WAIS-III Digit symbol 
WAIS-III Digit span 
WMS-III LM I & II, PAL I & II  
RAVLT  
WAIS-III Matrix Reasoning; COWAT; HSC; 
ROCFT; BADS Key Search  
TASIT 
Anderson et 
al., 2013 
Visual Working Memory  
Attentional Bias  
 
CCDT 
ACT 
Wang et al., 
2014 
Sensory-motor functioning  
Information Processing  
Attention  
Memory 
Verbal Fluency  
Executive Function  
Social Cognition  
 
MTT 
CRT; Verbal Inference; Switching of attention 
CPT; Time estimation 
R&R; WAIS-III Digit Span; Span of visual memory 
COWAT 
MT  
Emotional Identification 
Terrett et 
al., 2014 
Executive Function  
Prospective Memory  
Retrospective Memory  
 
COWAT; HSC; TMT A&B 
VW  
VW recognition 
Gupta et al., 
2014 
Motor Speed & Fine Coordination 
Processing Speed  
 
Attention/Working Memory  
Memory  
Verbal Fluency 
Executive Functions  
 
Grooved pegboard 
WAIS-III Digit symbol, Symbol Search, TMT-A, 
CT I 
PASAT, WMS-II Spatial Span  
HVLT-R, BVMT-R  
CLFT 
CT II, ST 
Liao et al., 
2014 
Cognitive Control  
 
 
SS 
Baldacchino 
et al., 2015 
Motor Impulsivity  
Non-planning Impulsivity  
Cognitive Impulsivity  
 
Go/NoGo 
SoC 
CGT 
Tolomeo et 
al, 2016 
Non-planning Impulsivity  
Cognitive Impulsivity  
 
SoC 
CGT 
Zeng et al., 
2016 
Working Memory  
Inhibition 
Decision Making  
2BT  
SS; ST 
IGT 
2BT=Two Back Task; 3D-BCM=Three Dimensional Block Construction Model; ACPT=Auditory Continuous Performance Task; 
ACT=Attentional Capture Task; BADS=Behavioural Assessment of Dysexecutive Syndrome; BNT=Boston Naming Test; BVMT-
R=Brief Visual Memory Test-Revised; BVRT=Benton Visual Retention Test; CCDT=Colour Change Detection Task; 
CGT=Cambridge Gambling Task; CLFT=Category and Letter Fluency Task; COWAT=Controlled Oral Association Word Test; 
CPT=Continuous Performance Task; CT I&II=Colour Trails Test; CRT=Choice Reaction Time; CVLT=California Verbal Learning 
Test; DDT=Delay Discounting Task; DSST=Digit Symbol Substitution Test; FAS=Phonological Fluency Test; GT=Gambling Task; 
HSC=Hayling Sentence Completion; HVLT-R=Hopkins Verbal Learning Test-Revised; IGT=Iowa Gambling Task; LNS=Letter 
Number Sequencing; MT=Maze Test; MTT=Motor Tapping Test PAL=Paired Associate Learning; PASAT=Paced Auditory Serial 
Addition Task; PM=Porteus Maze Test; RAVLT=Rey Auditory Verbal Learning Test; ROCFT=Rey Osterreith Complex Figures 
Test; RRLET=Remote and Recent Life Event Test; RSA=Ruff 2&7 Selective Attention Test; SAVF=Semantic Association of 
Verbal Fluency; SDMT=Symbol Digits Modalities Test; SOC=Stockings of Cambridge; SOMT=Six Object Memory Test; SS=Stop 
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Signal; SSST=Serial Seven Subtraction Task; ST=Stroop Test; TAP=Test for Attentional Performance; TMT A&B=Trails Making 
Test; WAIS=Weschler Adult Intelligence Scale; WCST=Wisconsin Card Sorting Test; WMS=Weschler Memory Scale; 
WSLT=Word Sequence Learning Test.     
 
Below, the findings of each study are reported in regard to whether significant differences 
between the opiate-dependent groups and control groups were found. Findings are considered 
for each cognitive domain. On a number of occasions studies used more than one psychometric 
test to assess a cognitive function which is categorised within the same cognitive domain. 
Therefore in some cases, studies reported significant group differences on one psychometric 
test, but not on another, within the same cognitive domain. Studies also commonly reported 
significant differences on one cognitive domain, and non-significant differences on another 
cognitive domain. 
3.2.1 Attention and Information Processing 
A total of 12 studies investigated ‘attention and information processing’ using a range of 17 
different neuropsychological tests. Eight studies reported significant group differences, with 
the opiate substitution group performing significantly worse on the studies chosen measures of 
attention and information processing (Anderson et al., 2013; Darke et al., 2000; Fadardi & 
Ziaee, 2010; McDonald et al., 2012; Messinis et al., 2009; Mintzer & Stitzer, 2002; Prosser et 
al., 2009; Rapeli et al., 2011). Rapeli and colleagues (2011) reported group differences between 
the methadone and control group, but not the buprenorphine and control group on the TAP. 
Messinis and colleagues (2009) reported mixed results, with the opiate substitution group 
performing significantly worse than the control group on one measure (SDMT), but not on 
another measure (CTT-I). Four further studies found no significant group differences (Gupta 
et al., 2014; Liao et al., 2014; Mehrjerdi et al., 2011; Wang et al., 2014). 
3.2.2 Short Term Memory 
A total of 11 studies investigated ‘short term memory’ using a range of 17 different 
psychometric tests. Nine studies reported significant group differences, with the opiate 
substitution group performing significantly worse on the studies chosen measures of short term 
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memory, including both verbal and visual working memory (Anderson et al., 2013; Darke et 
al., 2000; Lin et al., 2012; McDonald et al., 2012; Messinis et al., 2009; Mintzer & Stitzer, 
2002; Pirastu et al., 2006; Prosser et al., 2006; Rapeli et al., 2011). However, two of these 
studies also reported non-significant group differences on certain measures of short term 
memory (Lin et al., 2012; McDonald et al., 2012). Two studies reported no significant group 
differences (Gupta et al., 2014; Wang et al., 2014). 
3.2.3 Longer Term Memory 
A total of 10 studies investigated ‘longer term memory’ using a range of 10 different 
psychometric tests. Seven studies reported significant group differences, with the opiate 
substitution group performing significantly worse on the studies chosen measures of long term 
memory (Darke et al., 2000; McDonald et al., 2012; Messinis et al., 2009; Pirastu et al., 2006; 
Prosser et al., 2006; Rapeli et al., 2011; Terrett et al., 2014). However McDonald and 
colleagues (2012) reported mixed results, as they also found no significant group differences 
on two measures of long term memory. Three further studies reported no significant group 
differences on tests of longer term memory (Mintzer & Stitzer, 2002; Lin et al., 2012; Wang et 
al., 2014). 
3.2.4 Cognitive Impulsivity 
A total of eight studies investigated ‘cognitive impulsivity’ using a range of five different 
psychometric tests. All studies reported significant group differences with the opiate 
substitution group performing significantly worse on the studies chosen measures of cognitive 
impulsivity (Baldacchino et al., 2015; Fadardi & Ziaee, 2010; Gupta et al., 2014; Mintzer & 
Stitzer, 2002; Pirastu et al., 2006; Prosser et al., 2006; Tolomeo et al., 2016; Zeng et al., 2016) 
. However in two studies, significant differences were only reported on certain variables of a 
particular test, whilst no significant group differences were found on other variables within the 
same test (Tolomeo et al., 2016; Zeng et al., 2016). 
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3.2.5 Motor Impulsivity 
A total of three studies investigated ‘motor impulsivity’ using a range of three different 
psychometric tests. Only one study reported significant group differences, with the opiate 
substitution group performing significantly worse on the IGT (Zeng et al., 2016). Two studies 
reported no significant group differences (Baldacchino et al., 2015; Rapeli et al., 2011), 
although Baldacchino and colleagues (2015) reported a trend towards significance, with the 
opiate-substitution group performing worse than the control group. 
3.2.6 Non-Planning Impulsivity 
A total of five studies investigated ‘non-planning impulsivity’ using a range of five different 
psychometric tests. Four studies reported significant group differences, with the opiate 
substitution group performing significantly worse on the studies chosen measures of non-
planning impulsivity. However Wang and colleagues (2014) reported no significant group 
differences on Maze Test.   
3.2.7 Cognitive Flexibility 
A total of 11 studies investigated ‘cognitive flexibility’ using a range of eight different 
psychometric tests. Five studies reported significant group differences, with the opiate 
substitution group performing significantly worse than the control group on certain tests of 
cognitive flexibility, including both perseveration and verbal fluency (Darke et al., 2000; Gupta 
et al., 2014; McDonald et al., 2012; Messinis et al., 2009; Pirastu et al., 2006; Terrett et al., 
2014). Three of these studies reported mixed findings, as they also found no significant group 
differences on alternative measures of cognitive flexibility (McDonald et al., 2012; Messinis 
et al., 2009; Terrett et al., 2014). Four further studies only reported no significant groups 
differences on their chosen measures of cognitive flexibility (Mehrjerdi et al., 2011; Mintzer 
& Stitzer, 2002; Prosser et al., 2006; Wang et al., 2014). Gupta and colleagues (2014) reported 
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significant group differences on a test of verbal fluency, but no significant differences on a test 
of perseveration. 
4.1 Discussion 
4.1.1 Summary of findings 
Of the 19 studies that were reviewed, 17 studies reported that people in treatment for opiate-
use disorder performed significantly worse than healthy controls when tested on a variety of 
psychometric tests across a broad range of cognitive domains (attention and information 
processing, short and longer term memory, cognitive impulsivity, non-planning impulsivity, 
and cognitive impulsivity). However, of these 17 studies, 12 also reported no significant group 
differences on particular psychometric tests and/or particular cognitive domains. A final two 
studies reported no significant group differences across any of their psychometric tests (Liao 
et al., 2014; Wang et al., 2014). These findings reflect the complexity of assessing cognitive 
impairment, with a plethora of psychometric tests available to assess the same cognitive 
domain. Only five studies reported significant group differences on all of their psychometric 
tests; the more usual pattern was complex with studies finding significant group differences 
within certain cognitive domains, but not in others. 
These findings are comparable to existing reviews and meta-analyses that report broad 
cognitive impairment across a range of domains in people under methadone maintenance 
treatment when compared to healthy controls (Baldacchino et al., 2012; 2017; Wang et al., 
2014). In 2017, Baldacchino and colleagues meta-analysis reported significant group 
differences with medium-large effect sizes (d=0.41-1.38) on all seven cognitive domains. The 
statistical analyses indicated that across the 21 studies included in their review, overall the 
methadone maintenance groups performed significantly worse on all cognitive domains when 
compared to a healthy control group. No reviews exist which include alternative substitution 
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drugs such as buprenorphine. The current literature review suggests that people with an opiate-
use disorder taking buprenorphine also show cognitive impairment across a range of domains. 
However fewer primary studies and therefore a smaller sample size contributed to this finding, 
meaning it is not possible to make conclusive statements. 
As this review is not quantitative it was not possible to directly compare these findings to that 
of existing meta-analyses. However it is interesting to note this review included 12 studies that 
were also included in Baldacchino’s 2017 review. It does not seem that these seven studies 
were those which have less stringent inclusion/exclusion criteria, and the pattern of results 
across these studies appear no different to the pattern of results across the other 12 studies. 
Furthermore, in contrast to Baldacchino’s claims, eight studies included in the 2017 review, 
also included in this review, may have included participants with other drug dependencies or 
use, mental health diagnoses such as anxiety or depression, and a history of overdose 
(Baldacchino et al., 2015; Darke et al., 2000; Gupta et al., 2014; Liao et al., 2014; McDonald 
et al., 2012; Tolomeo et al., 2016; Wang et al., 2014;). More research is needed to investigate 
the level of cognitive impairment in a typical opiate-dependent population in treatment for 
opiate-substitution. The question remains as to whether these people would be more severely 
impaired than the people most often included as participants in existing studies. 
4.1.2 Strengths and Limitations 
All data in this literature review are gathered from cross-sectional, uncontrolled, and non-
randomised study designs. Unfortunately these investigations do not lend themselves to 
randomised controlled trials, and therefore the generalisability of these studies are limited. 
Sampling biases can mean that people who take part in research studies may not be sufficiently 
representative of a particular group of individuals. Opiate-using populations can be difficult to 
engage and it is possible that the participating individuals in these studies consist of a more 
motivated group who are fully engaged with their treatment (Ornstein et al., 2000). Therefore 
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individuals with the greatest cognitive impairment may not be included in these studies, 
resulting in a possible underestimation of the severity of cognitive impairment.  
All primary studies are of mixed methodological quality. These factors have a direct impact on 
the interpretability of this review’s findings. Despite best efforts many studies had difficulty 
matching drug and control groups on variables such as age, education, and IQ. There is ongoing 
concern that cognitive impairment reported in opiate-using populations actually reflects pre-
existing differences in ability and achievement. In fact, research suggests that lower IQ could 
be a risk factor for drug abuse (Block et al., 2002). Of the 19 studies reviewed, the opiate-
dependent groups completed an average of 10.8 years in education, 1.6 years less than the 
control group (12.4 years).  Out of the 18 studies that reported years in education, only seven 
studies matched the drug and control groups on this variable (Darke et al., 2000; Gupta et al., 
2014; Liao et al., 2014; Messinis et al., 2009; Mehjerdi et al., 2011; Mintzer & Stitzer, 2002; 
Terrett et al., 2014).  Eleven studies reported that the control group completed significantly 
more years in education than the drug groups, with one study reporting a difference of 5.1 years 
(Lin et al., 2012). Furthermore 13 of the 19 studies generated an estimated pre-morbid IQ score 
using a range of well-validated measures (WAIS; NART; WTAR). Approximately half of these 
studies (6) found that the healthy controls had a significantly higher estimated pre-morbid IQ. 
It is important to note that although some of these studies consequently included IQ as a 
covariate in their analyses, to control for these differences (Baldacchino et al., 2015; McDonald 
et al., 2012; Prosser et al., 2006; Tolomeo et al., 2016), others failed to (Pirastu et al., 2006; 
Prosser et al., 2009). Therefore it is possible that the studies which showed significant group 
differences in years in education and/or IQ, and did not subsequently control for these 
differences in the analysis, have ignored the influence of pre-existing differences on 
performance. It may be that the significant group differences reported by Pirastu and colleagues 
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(2006), and Prosser and colleagues (2009), are better explained by pre-morbid functioning, 
rather than a consequence of opiate-use. 
Many of the studies carried out a large number of group comparisons across a range of 
psychometric test variables. However, few studies reported appropriate Bonferroni corrections 
to control for family-wise error (Baldacchino et al., 2015; Gupta et al., 2014; Liao et al., 2014; 
Wang et al., 2014). Consequently, studies that did not employ necessary corrections are at risk 
of incorrectly rejecting the null hypothesis (type I error), stating there are significant group 
differences in cognitive functioning, when in fact there are not. Although some studies reported 
results with highly significant p-values (p<0.001) (Darke et al., 2000), others interpreted p-
values of 0.03-0.05 as significant, despite performing multiple tests (Messinis et al., 2009). 
However when reviewing significance levels it is also important to consider sample sizes. The 
larger the sample size the better the probability of detecting a real effect (power). Studies with 
small sample sizes have low power and therefore poor sensitivity to detect group differences 
that may be present. Small sample size studies are therefore at risk of underreporting group 
differences as they may not reach significance. Therefore the use of effect sizes can be a more 
appropriate method of reporting group differences as it does not confound with sample size. 
However only nine studies in this review reported effect sizes in their results.  
In addition to the varying methodological limitations of the studies, it was important to question 
whether inconsistent findings may be unsurprising, considering the heterogeneity in an opiate-
dependent population (Ersche & Sahakian, 2007). Individuals meeting the criteria for an 
opiate-use disorder with a duration of illicit drug use at 6 months may be less impaired than 
individuals using for over 10 years. Some research suggests a correlation between length of 
previous heroin abuse and cognitive impairment, with abuse longer than a year being associated 
with short term memory and learning deficits (Mitrovic et al., 2011). In contrast, however, 
studies included in this literature review reported no correlation between cognitive impairment 
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and years of heroin abuse (Darke et al., 2000; Prosser et al., 2006). As many participants 
reported very long heroin abuse duration (overall mean=12.4 years), it is possible that these 
studies may be observing a ceiling effect which may mask any slight differences in impairment. 
Research shows there is an acute sedative effect of methadone, in particular on psychomotor 
performance, which resultantly impacts performance on cognitive testing (Darke et al., 2000; 
Lombardo et al., 1976). The majority of primary studies carefully considered these acute 
sedative effects by ensuring participants were both in treatment for a minimum amount of time 
(i.e. 3-6 months), and were adequately stabilised on their dose (i.e. for at least 1 month). 
However four studies lacked the necessary information to determine whether participants were 
stabilised on the opiate-substitution (Fadardi & Ziaee, 2010; Gupta et al., 2014; Mehrjerdi et 
al., 2011; Zeng et al., 2016). Furthermore, participants in Mehrjerdi and colleagues’ (2011) 
study had only been in treatment for 17 days. It is possible that cognitive impairment reported 
in these studies could have been influenced by poor psychomotor speed caused by the sedative 
effects of the substitution drug, rather than reflecting a more stable impairment. 
4.1.3 Typical treatment seeking opiate-dependent populations 
This literature review aimed to include studies which recruited a typical and heterogeneous 
group of people in treatment for opiate-use disorder. It was not concerned with determining a 
causal relationship between specific factors (i.e. opiate-use alone) and cognitive impairment. 
Notably, there was a substantial lack of studies which included participants who reported 
factors that are commonly occurring in opiate-using populations, such as other drug use, 
alcohol use, head trauma, overdoses, and other mental health diagnoses. Research suggests 
high rates of poly drug use in opiate-using populations (PHE, 2017) and high rates of co-morbid 
depression in people in methadone maintenance treatment (Harvard et al., 2006). Importantly 
these presentations have a direct impact on treatment outcomes, as people with concurrent 
mental health diagnoses have poorer psychosocial functioning (Kennedy & Paykel, 2004), and 
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experience more relapses (Trivedi et al., 2008). Furthermore, Verdejo and colleagues (2005) 
reported that a significant proportion of people receiving methadone substitution for an opiate 
addiction also report a history of alcohol abuse, use of other illicit drugs, and overdoses 
(Verdejo et al., 2005). Notably, eight studies used urine analysis to objectively confirm that 
participants had been abstaining from other illicit drugs for long periods of time (3-18 months) 
before testing. The remaining studies either used urine analysis only to confirm abstinence at 
time of testing (n=4), or used clinician opinion at time of testing (n=3), or made no statement 
about confirming abstinence/drug use (n=4). The studies which used urine analysis to identify 
a successfully drug abstinent population could be underestimating the level of cognitive 
impairment that may be present in a more typical treatment seeking drug using population. 
Finally, it is important to emphasise that the data included in this review are limited by what is 
made available in the published studies. A number of studies lacked detail in the write-up with 
regard to describing their participant population, describing methods for statistical analysis, 
and displaying details of the results. Nonetheless, studies which did adequately define their 
inclusion and exclusion criteria did not necessarily then describe their participant group with 
regard to these. For example studies which included head trauma did not always state how 
many participants actually reported head trauma. This missing information made it even more 
difficult to determine whether the studies with less stringent inclusion/exclusion criteria 
actually recruited a typical drug-taking population, or whether issues such as sampling bias 
limited the likelihood of factors such as polydrug use, head trauma, overdose, and other mental 
health diagnoses being present in their drug-taking participant groups. 
4.1.4 Implications 
Deficits on particular cognitive domains are likely to have profound consequences for 
individuals engaging in drug addiction treatment. Slower processing speed results in 
difficulties performing learnt tasks. This can have an impact on an individual’s pace, which 
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can consequently impact everyday routines such as arriving at appointments on time, to 
completing tasks outlined in treatment. This could lead to frustration and disengagement if 
services do not take into account these deficits and make necessary adaptations. Deficits in 
verbal memory and learning may make it difficult to understand complex instructions as well 
as impairing the ability to learn and remember this information over delayed periods, an 
integral aspect of facilitating change during treatment. Furthermore, McDonald and colleagues 
(2012) reported a significant relationship between poor cognitive function and poor social 
cognition. Such deficits may directly impact an individual’s social communication and 
interaction skills, making it more difficult to engage with professionals and services. 
Executive dysfunction, such as impulsivity may result in poor problem solving and risk taking 
behaviours. Indeed, Barry and Petry, (2008) discussed difficulties anticipating and considering 
negative long term consequences in substance dependent individuals which are integral 
processes that facilitate recovery. Furthermore, prospective memory impairment is likely to 
have real world consequences, for example forgetting to attend appointments, taking 
medication, or paying bills on time (Terrett et al., 2014). People attending drug services for 
opiate addiction may therefore benefit from wide-ranging support, including personal 
effectiveness programs and adult daily living skills (Prosser et al., 2006). 
It is also necessary to consider the impact of co-occurring factors, such as mental health 
diagnoses and alcohol use, on treatment engagement and efficacy in opiate-dependent 
populations. The high frequency of concomitant alcohol use in opiate-dependent populations 
(Verdejo-Garcia et al., 2005), and its known impact on cognitive functioning is an important 
factor for services to consider. Darke and colleagues (2000) suggest that a lifetime diagnosis 
of alcohol dependence could be routinely screened for if trying to determine the likelihood of 
cognitive impairment. In addition, McDonald and colleagues (2012) reported that the majority 
of their opiate-substitution participant (total n=125) group reported a history of overdose. 
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Overdose can lead to hypoxia which can starve the brain of oxygen and consequently result in 
permanent damage to the brain. There is also research to show that people with a diagnosis of 
depression in treatment for opiate-dependence are more likely to use other illicit drugs 
(Compton et al., 2003). All of these factors may reduce both treatment engagement and 
efficacy, and should be considered by all involved in an individual’s treatment in services 
treating opiate-use disorder.  
4.2 Conclusions 
The paucity of studies which include opiate-dependent participants who also reported factors 
such as polydrug and alcohol use, history of overdose or head trauma, and other mental health 
diagnoses, highlights the need for more studies to investigate cognitive impairment in a typical 
treatment seeking opiate-dependent population. Until then it is not possible to confidently 
report on the level of cognitive impairment in this population. However the results of this 
review, and of existing reviews, indicate significant levels of impairment across a broad range 
of cognitive domains in people attending services for opiate-use disorder. These findings are 
in spite of stringent inclusion and exclusion criteria and it could be hypothesised that there is 
an underestimation of cognitive impairment in a population who are much more heterogeneous 
and complex, with regard to their drug-taking patterns and experience of other significant 
difficulties, such as mental health. 
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PART 3: CLINICAL EXPERIENCE 
 
Year 1  
Adult Community Mental Health Recovery Service 
I worked with adults aged 18-65 years old, presenting with a range of moderate to severe mental 
health difficulties, in a community setting. I worked with people with a range of mental health 
diagnoses and difficulties including: depression, anxiety, OCD, psychosis, emotionally unstable 
personality disorder, post-traumatic stress disorder, bipolar disorder, a history of traumatic 
experiences (child abuse, neglect), self-harm and suicidal behaviours. 
I worked on an individual basis with a number of people, providing assessment and interventions. 
Therapeutic models which informed my work included Cognitive Behaviour Therapy (CBT), 
Dialectical Behavioural Therapy (DBT e.g. distress tolerance), Mindfulness, and Attachment 
theory. I also worked with my supervisor in delivering Family Intervention for Psychosis with a 
family of 2 adults and 2 children.  
I co-facilitated two groups whilst on placement. I facilitated a psycho-educational CBT group with 
another trainee clinical psychologist, and other members of the MDT when appropriate, i.e. OT. 
The group was a 6 week programme offered on a rolling basis and covered the basics of CBT; the 
link between thoughts, feelings, behaviours, and physiological sensations, behavioural 
experiments, and the importance of self-care. I also facilitated a therapeutic group for people with 
a diagnosis of bipolar disorder, with a clinical psychologist. This was an 8 week programme which 
included psycho-education, mindfulness techniques, and strategies to manage difficulties 
associated with the diagnosis, i.e. lows and highs.  
I also conducted a service-related project on this placement, evaluating the effectiveness of a 
hoarding group, run in partnership with a charity. 
I completed two neuropsychological assessments; the first was to produce a cognitive profile for 
an individual who had recently experienced a head injury. The second was a memory assessment 
of an adult with a diagnosis of Bipolar Disorder reporting memory difficulties. 
As part of my teaching and training competencies, I delivered a presentation to the service user and 
carer group within the service, on offering a psychological perspective to mental health difficulties, 
and understanding what psychology can offer. I also delivered a presentation in a team meeting 
regarding the STEPPS group and referral process. 
I attended and contributed to different meetings including Multi Disciplinary Team (MDT) 
meetings, psychology team meetings, psychology locality meetings, complex case discussions, and 
business meetings. 
 
Year 2  
Child and Adolescent Mental Health Service (CAMHS) Tier three and a Pupil Referral Unit 
Tier Two 
On my CAMHS placement I worked with children and young people aged 10-17 years old and 
their families. Difficulties experienced by the children and young people I worked with included 
moderate to severe mental health difficulties including, anxiety (panic disorder, generalised 
anxiety disorder, social anxiety), obsessive compulsive disorder (OCD), low mood, low self-
esteem, self-harm, gender identity difficulties, anger management, and Autism Spectrum 
Disorder (ASD). I used a range of models to inform my assessments and interventions including 
CBT, narrative therapy, parenting approaches, attachment theory, and systemic theory. My 
interventions consisted of individual, family-based and parent work.  
I led the development of a new 6-week yoga group for teenagers struggling with low mood and 
anxiety, which was evaluated using pre- and post- measures. I co-facilitated this group with a 
qualified yoga teacher. I delivered a presentation about this new project at a CAMHS learning 
event to service leads. 
At the Pupil Referral Unit I completed two neuropsychological assessments of two primary 
school aged children to determine cognitive profiles of their strengths and difficulties in light of 
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educational attainment difficulties, and in the context of neurodevelopmental difficulties such as 
ASD and ADHD. These assessments involved making contact with hard-to-reach families to 
gather developmental histories, completing school observations, and gathering information from 
teaching staff and SENCOs. These assessments were fed back to the PRU and mainstream 
schools, and further consultation was offered to schools. I also supported the development of a 
reflective practice group for the school teachers at the PRU.  
 
Older People’s Memory Assessment Service  
I worked with older people from the age of 65 to 90, who had received a diagnosis of dementia, 
including Alzheimer’s Disease, Vascular dementia, and Lewy Body dementia. People struggled 
with difficulties including adjustment to the dementia, physical health issues, relationship and 
familial difficulties, and further mental health difficulties such as depression. 
I carried out two comprehensive neuropsychological assessments to determine the presence of a 
dementia, including differential diagnosis (dementia vs. depression), and determining the type of 
dementia. This involved gathering information from the individual and informants, and offering 
feedback and making onward referrals to appropriate services. 
I led and co-facilitated the running of a 10-week group with a nurse ‘Living well with dementia’. I 
adapted materials to ensure they were effectively tailored to the participants in the group. This 
group explored what the diagnosis meant, both medically and to the individual. We looked at 
strategies that could support people to cope, and live alongside dementia. We explored the difficult 
emotions often associated with receiving a diagnosis, and what this meant for the future. The group 
was evaluated using pre- and post- measures, and qualitative feedback was gathered from the 
individual and family members in the final session.  
I worked both individually and with couples supporting the adaptation to a recent diagnosis of 
dementia. My work was informed primarily by systemic theory, narrative approaches, and solution-
focused techniques. My practice was also informed by attachment theory, CBT, ACT, mindfulness, 
and health psychology models.   
I co-facilitated a reflective practice group for dementia support workers to offer a space to explore 
the emotional impact of the role, informed by a solution-focused approach, building on the skills 
and knowledge of colleagues to work through difficulties.  
I attended MDT meetings, journal club sessions, and I presented to the team on the use of a 
dementia screening tool.  
I co-facilitated an information and support session with a clinical psychologist and OT for 
individuals who had recently received a diagnosis of dementia, and their family members.  
I supervised the work of a graduate psychology student completing a service evaluation; I offered 
support on the design of focus groups and gathering feedback, the use of quantitative and qualitative 
evaluation methods, and qualitative analysis methods.  
 
Year 3  
Specialist Placement – Paediatric Psychology Service  
On my specialist placement, I worked in a paediatric psychology service for children and young 
people with physical health difficulties. I worked with children and families ranging between the 
ages of 2 and 12 years with a range of difficulties including; Sickle Cell Disease and pain, Cerebral 
Palsy, medically unexplained symptoms, procedural anxiety, behavioural difficulties, toileting 
difficulties and ASD, adjustment issues, and cognitive impairment. I also worked with parents 
experiencing emotional distress and anxiety regarding their child’s illness and relationship 
difficulties in the context of their child’s diagnosis and treatment.  
I carried out assessment and interventions on an outpatient basis, working with children 
individually, parents separately, and I also worked with families together. Interventions were 
tailored to the individual needs of the child and their families based on working formulations. The 
main models applied on this placement were systemic family therapy, narrative, brief solution 
focused, CBT, ACT, and behavioural approaches, alongside psycho-education and basic 
127 
 
therapeutic skills/interventions involving validation and listening. Much of my work also included 
liaising with other services and organisations such as schools and CAMHS. I organised and 
facilitated TAC meetings, and supported schools in better supporting their pupil.  
I carried out two neuropsychological assessments for children; one who had Sickle Cell Disease, 
and another where there were concerns about cognitive difficulties in light of toileting issues and 
ADHD. Based on the assessments, I provided feedback to families and schools regarding 
underlying cognitive abilities, memory, concentration and attention (executive functioning) issues. 
I delivered a presentation to the psychology team about the new Power Threat Meaning Framework 
in their service development meeting. I also attended the team away day where considerable 
thought was given to service development and the future of the service. 
I attended in-house training on a number of topics including; motivational interviewing, paediatric 
intensive care – death and dying; constipation, obesity, anxiety and autism, complicated grief, tree 
of life, functional neurological disorders, and ethics. I attended weekly psychology team meetings, 
and also attended the neurology and neurosurgery MDT.  
I developed a number of tailored therapeutic materials, including resources, social stories, and 
accessible cognitive assessment summaries. I also wrote systemic therapeutic letters to the children 
I worked with.  
 
Community Mental Health Team for People with Learning Disabilities   
I worked with adults aged 18-65 years of age who had a recognised Learning Disability, and a 
Mental Health diagnosis. People had diagnoses of psychosis/schizophrenia, anxiety, depression, 
and  PTSD. People had difficulties associated with identity, managing transitions, anger difficulties, 
self-harm, suicidal ideation and behaviours, relationship difficulties, and behaviour that challenges. 
I also worked with people with ASD and an LD. I worked with people with a high level of risk, to 
themselves, to others, and from others. I worked with people with criminal histories. Risk 
assessment and management formed a significant proportion of my work. 
I worked therapeutically with people with mental health difficulties (such as those mentioned 
above). Assessments and interventions were tailored and adapted to individual needs, taking into 
consideration the learning disability, communication difficulties and sensory difficulties. I carried 
out both individual and indirect (family, carers, staff) interventions using CBT, DBT and systemic 
based approaches, incorporating attachment theory and narrative approaches. I worked 
individually, as well as with a person’s support worker. I also worked with a family of a man with 
a diagnosis of Schizophrenia and LD, who was refusing their medication. We supported the family 
throughout the person’s deterioration in mental health, inpatient admission, and discharge. 
A significant proportion of my work involved joint working with other members of the MDT, 
including nurses, psychiatrists, Occupational Therapists and Speech and Language Therapists.  
My work also included assessment, formulation, training and consultation to care home staff 
regarding risk management and challenging behaviour, using functional assessments and the 
Positive Behaviour Support (PBS) model. I delivered 3 training sessions to care home managers 
on PBS, and developed a PBS plan for one of our clients.   
I carried out two neuropsychological assessments; one eligibility assessment for an 18 year old 
man with ASD. I also used the BPVS, a test of receptive vocabulary, to identify a client’s 
communication abilities, and used this information to inform a PBS plan. 
I facilitated 3 groups for a community service for people with learning disabilities, to people with 
a range of presenting difficulties and abilities. The groups were on friendships and relationships, 
and anxiety and relaxation.  
I delivered a presentation to the psychology team about the new Power Threat Meaning Framework 
in their service development meeting. This helped help promote psychological thinking and 
formulation within the MDT. I also attended several MDT meetings, and local and countywide 
faculty meetings. I learned about the perspectives and experiences of people with learning 
disabilities and their carers by attending several day centres.  
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PART 4: PSYCHD CLINICAL PROGAMME 
TABLE OF ASSESSMENTS COMPLETED DURING TRAINING 
 
Year I Assessments 
ASSESSMENT TITLE 
WAIS WAIS Interpretation (online assessment) 
Practice Report of 
Clinical Activity 
Assessment and formulation of Max, a white British 
male in his early thirties experiencing psychosis. 
Audio Recording of 
Clinical Activity with 
Critical Appraisal 
Audio recording and critical appraisal of an individual 
CBT session with a female in her mid-thirties presenting 
with obsessional worries and avoidance behaviours. 
 
Report of Clinical 
Activity N=1 
Cognitive Behaviour Therapy with a British woman in 
her mid-thirties presenting with obsessional difficulties 
and avoidance behaviours. 
Major Research Project 
Literature Survey 
Cognitive impairment in substance-dependent 
populations: A literature survey. 
Major Research Project 
Proposal 
Exploring the experience of cognitive impairment in 
opiate-dependent populations. 
Service-Related Project Evaluation of a self-help group for people with hoarding 
difficulties and their carers. 
 
Year II Assessments 
ASSESSMENT TITLE 
Report of Clinical 
Activity/Report of 
Clinical Activity – 
Formal Assessment 
A neuropsychological assessment of a female in her late 
eighties investigating the presence of a dementia. 
PPLD Process Account A reflective account of the process of attending a personal 
and professional group. 
 
Year III Assessments  
ASSESSMENT TITLE 
Presentation of Clinical 
Activity 
A presentation of an integrative psychological 
intervention with a 10 year old boy with a diagnosis of 
obsessive-compulsive disorder attending a Child and 
Adolescent Mental Health Service 
Major Research Project 
Literature Review 
Cognitive impairment in opiate-dependent populations 
receiving an opiate-substitution: A literature review. 
 
Major Research Project 
Empirical Paper 
Exploring the experience and understanding of cognitive 
impairment in chronic opiate-users. 
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Report of Clinical 
Activity/Report of 
Clinical Activity – 
Formal Assessment  
Integrative systemic therapy with a young person 
presenting with chronic abdominal pain and anxiety and 
her mother. 
Final Reflective 
Account 
On becoming a clinical psychologist: A retrospective, 
developmental, reflective account of the experience of 
training 
 
 
 
 
 
